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1 CHAPTER I: Introduction 
1.1 Tissue Engineering and Cancer Research 
Tissue engineering is an emerging research area that offers outstanding opportunities for 
regenerative medicine, a field seeking to relieve patients from suffering the 
consequences of diseases and injuries by restoring the function of their damaged tissues 
and organs [Cortesini, 2005]. One of the first definitions of tissue engineering was given 
in 1993 by Langer and Vacanti who defined it as “ an interdisciplinary field that applies 
the principles of engineering and life sciences towards the development of biological 
substitutes that restore, maintain, or improve tissue or organ functions” [Langer and 
Vacanti, 1993]. Although the field of tissue engineering has focused mainly to date on 
direct clinical applications in regenerative medicine, tissue engineering offers a 
potentially powerful tool box for other areas in the biomedical sciences. There is a 
natural convergence between tissue engineering and cancer biology that has already 
sparked collaborative efforts between experts in both fields [Burdett, 2010]. Recent 
literature demonstrated how tissue engineering platforms can enhance in vitro models of 
tumorigenesis and thus hold great promise to contribute to future cancer research (Figure 
1). Tissue engineering offers the exciting possibility to partner with cancer researchers to 
design and fabricate matrices that mimic major components of the natural and tumor 
extracellular matrix (ECM) from both a structural and functional point of view 
[Hutmacher, 2009a]. 
 
Fig.1) Tissue engineering concepts as a powerful tool box for cancer research areas [Hutmacher, 
2009a]. 
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1.1.1 Cancer and conventional cancer cell studies 
Cancer is one of the most common and serious diseases in the world, after heart diseases. 
A report from World Health Organization accounted for 7.6 million deaths (around 13% 
of all deaths) in 2008. About 70% of all cancer deaths occurs in low and middle-income 
countries. Deaths from cancer worldwide are projected to continue to rise to over 13.1 
million in 2030. Cancer is a term used for disease in which not one, but several, 
mutations are required. Cancer arises from one single cell. The transformation from a 
normal cell into a tumor cell is a multistage process, typically a progression from a pre-
cancerous lesion to malignant tumors. Each mutation drives a wave of cellular 
multiplication associated with gradual increase in tumor size, disorganization and 
malignancy [Volgestein, 1993]. These changes are the result of the interaction between a 
person's genetic factors and three categories of external agents, including: physical 
carcinogens, such as ultraviolet and ionizing radiation; chemical carcinogens, such as 
asbestos, components of tobacco smoke, aflatoxin (a food contaminant) and arsenic (a 
drinking water contaminant); and biological carcinogens, such as infections from certain 
viruses, bacteria or parasites. It consists in an abnormal growth of cells, which tend to 
proliferate in an uncontrolled way and in some cases to metastasize (spread). Cancer 
cells can spread to other parts of the body through the blood and lymph systems. Cancer 
types can be grouped into broader categories. The main categories of cancer include: 
-Carcinoma: cancer that begins in the skin or in tissue that line or cover internal organ. 
There are a number of subtypes of carcinoma, including adenocarcinoma, basal cell 
carcinoma, squamous cell carcinoma, and transitional cell carcinoma. 
-Sarcoma: cancer that begins in bone, cartilage, fat, muscle, blood vessel, or other 
connective or supportive tissue. 
-Leukemia: cancer that starts in blood–forming tissue such as the bone marrow and 
causes large numbers of abnormal blood cells to be produced and enter the blood. 
-Lymphoma and myeloma: cancer that begins in the cells of the immune system. 
-Central nervous system cancers: cancer that begins in the tissues of the brain and spinal 
cord. 
The vast majority of in vitro studies, particularly in the cancer field, are performed in 
two-dimensions (2D) such Petri dishes, multi-well plates or glass slides that have been 
coated with various proteins, such as collagen, laminin and fibronectin, to simulate the 
ECM environment. 
Previously 2D monolayers and organ cultures have been the most popular in vitro 
models for cancer research due to their simplicity [Yang, 2007]. 2D monolayer culture 
models are easy and convenient to set up with good viability of cells in culture [Kim, 
2005]. Studies in standard cell culture have produced many results to help cancer and 
molecular biologists to interpret complex biological phenomena, hypothesis and to test 
anticancer drugs. In vitro testing of anticancer drugs typically involves growing cancer 
cell lines in monolayers on tissue culture plastic and using high-throughput screening 
procedures to evaluate drug efficacy. This component of cancer drug testing began in the 
late 1980s when the National Cancer Institute established a panel of 60 unique cancer 
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cell lines for use in screening antineoplastic drug candidates. Since then, hundreds of 
other cancer cell lines have been used with similar intent. Additionally, the widespread 
adoption of bioinformatics profiling has yielded valuable information about cancer 
biology, leading to the discovery of antineoplastic drugs with novel mechanisms of 
action, and helped to delineate resistance mechanisms for several cancer types [Burdett, 
2010]. Despite these advances, the monolayer culture remain a poor predictor of whether 
a given drug will ultimately yield clinical benefit, in fact monolayer cultures poorly 
represent in vivo tumor behavior. There are several limitations associated with 2D cell 
culture experiments, such as lack of reproduction of physiological patterns of cell 
adherence, cytoskeletal organization, migration, signal transduction, morphogenesis, 
proliferation, differentiation and response to therapeutic stimuli [Hutmacher, 2009b]. 
One way to better replicate the biological complexity of human tumor growth is to study 
human cancer within an animal model. This provides tumor cells with many of the three-
dimensional (3D) microenvironmental cues that are missing during monolayer growth. 
The most common mouse model employed in drug testing for solid tumors is the 
subcutaneous human tumor xenograft. As with in vitro testing, many drugs appear 
promising when tested in xenografts, but several studies involving a variety of tumor 
types have found a general lack of correlation between the human tumor xenograft 
response data and the results of phase II clinical trials. Although these models often 
provide more biologically relevant data, the complexity and difficulty of the experiments 
often precludes their widespread use, they are not currently available for all cancer types, 
and they still have limitations related to the foreign mouse physiology [Burdett, 2010]. 
The biology of human cancers can be studied on human tumor samples obtained at 
surgery. Such pathological samples present the real state of the tumor in vivo. They can 
be used to define their pathology, gene expression and metabolism. However, the 
interpretation of the findings must take into account the complexity and heterogeneity of 
solid tumors, and that samples represent only one late time point in the evolution of the 
lesion. Studies revealed that at the time of their diagnosis, solid tumors are already at the 
last quarter of their life: a minimum of 30 cell divisions is necessary to achieve a mass of 
1 g, while another 10 divisions could bring the tumor to the potentially lethal size of 1 
kg. Human tumor samples as such are not amenable to experimentation, which requires 
the use of appropriate model [van Staveren, 2009]. 
To address many of the problems identified above, researchers have sought to create 3D 
in vitro cancer models that better mimic in vivo tumor biology. Experimentation on 
models is necessary for the following reasons: 
-To obtain a dynamic view of a cancer from its origin to the later stages observed in 
patients, i.e. of its physiopathological evolution. 
-To test hypotheses about the origin, pathogenesis and physiopathology of human 
tumors. 
-To investigate in detail the physiopathological pathways. 
-To screen and test chemical compounds as potential drugs. 
-To define potential diagnostic signatures [Elliot, 2010]. 
Therefore, to successfully investigate the pathobiology of human cancer, it is necessary 
to maintain or recreate the characteristic 3D architecture of the tissue in culture. 
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1.1.2 Engineering tumors: a tissue engineering perspective in 3D 
There is an increasing recognition that 3D tissue culture technologies have many uses 
within the biomedical sciences beyond the scope of regenerative medicine. One such use 
is in the field of cancer biology, where a 3D tumor model that accurately recreates the in 
vivo tumor phenotype would be a valuable tool for studying tumor biology and would 
allow better preclinical evaluation of anticancer drug candidates. [Burdett, 2010]. To 
successfully investigate the pathobiology of human cancer, it is necessary to maintain or 
recreate the characteristic interplay between malignant cells and surrounding 
environment in tumors [Birgersdotter, 2005]. Recent advances in 3D culture and tissue 
engineering techniques have enabled the development of more complex heterologous 3D 
tumor models. They can, in principle, reproducibly reflect the distinct invasive behavior 
of human tumor cells, mimic the tumor–ECM cell interactions of human cancer and 
allow for systematic investigation into the multiple unknown regulatory feedback 
mechanisms of the tumor cells in a well-defined 3D environment [Kim, 2005]. Recently, 
3D cultures within a matrix, also termed ‘‘scaffold’’, were proposed as a better model to 
study complex biological processes than cells grown in monolayer [Xu, 2007]. Cancer 
cells grown into a tissue-like structure in a matrix may closely mimic the biology of 
tumor development in vivo and hence can serve a better model system for preclinical 
evaluation of the cytotoxic effect of anticancer agents [Jacks, 2002]. 3D in vitro models 
allow cells to develop into structures similar to those in living organisms and thus enable 
researchers both to perform genetic manipulations and to observe some of the biological 
changes [Xu, 2007]. The mechanisms of aberrant proliferation and invasion in cancer 
have been analyzed fruitfully in 3D model systems [Bissell, 2005; Debnath, 2005; Kim, 
2005]. Increased use of 3D models that mimic specific tissues should promote advances 
in tissue engineering and could also facilitate the development and screening of new 
therapeutics [Yamada, 2007] A tissue-engineered tumor model that recreates the 3D 
structure, tumor environment, and signaling milieu present in vivo could dramatically 
improve the current preclinical drug screening paradigm by providing valuable 
information about drug efficacy early in the drug development process. This is especially 
important for less common cancers, where limited patient numbers preclude widespread 
drug testing in phase I/II trials [Burdett, 2010]. 
1.1.2.1 Tissue architecture and tumor microenvironment 
In mammalian tissue, cells connect not only to each other, but grow within an organized 
3D matrix, a complex network composed of proteins, carbohydrates and growth factors 
called the ECM [Lodish, 2001]. The dynamic, heterogeneous composition of the ECM 
provides a wide range of biological, chemical, and mechanical properties. The structure 
of all organs is comprised of specific cells and ECM components organized to facilitate 
its physiological functions [Unsicker, 2010]. The ECM generally includes two classes of 
proteins: insoluble and soluble. Collagen is the major insoluble fibrous protein in the 
ECM and accounts for nearly 30% of all proteins found in the body. Of the 28 different 
types of collagen, 80–90% consist of types I, II, III, and IV. Collagens are distinguished 
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by their ability to form fibers with high tensile strength and to organize into networks, 
providing structural and connective support for tissue. The ECM contains two major 
soluble proteins: multiadhesive matrix proteins and proteoglycans [Badylak, 2009]. 
Multiadhesive matrix proteins have multiple domains that interact with various types of 
collagen and cell surface adhesion molecules, and are responsible for attaching cells to 
the ECM and initiating various cellular responses. Laminin and fibronectin are two 
important multiadhesive proteins in the ECM. With 15 types identified, laminin is the 
most abundant constituent of basal lamina after type IV collagen. Fibronectin is 
primarily involved in attaching cells to all matrices that contain fibrous collagen. 
Importantly, the most common protein mimetic peptide, Arginine-Glycine-Aspartic Acid 
(RGD), is used for cell adhesion in tissue engineering and is based on the cell 
recognition site of fibronectin. Proteoglycans are another major constituent of the ECM. 
The basic proteoglycan contains a core protein with one or more covalently bound 
polysaccharide chains [Birkedalhansen, 1995]. Many ECM and cell surface 
proteoglycans facilitate cell–matrix interactions and help present certain growth factors 
to their cell-surface receptors [Baudino, 2010]. Hyaluronan (HA) is an extremely long 
(5–20,000 kDa), negatively charged polysaccharide, which forms highly hydrated gels 
[Louderbough, 2010]. 
Moreover one of the ECM components is the basement membrane (BM), which is a 
specialized form of the ECM that is found in several forms throughout the body. In 
epithelial tissues, a major BM separates the epithelial cell population from the mixture of 
mesenchymal cell types that is collectively termed the stroma. This BM is a key player 
both in the maintenance of normal tissue architecture and in tumor development [Jacks, 
2002]. The microenvironment can send signals to a cell through soluble factors in the 
interstitial fluid, cell/cell or cell/ECM adhesion, or mechanical forces. The signals are 
transmitted within the cell, inducing a cascade of interactive events at various levels. The 
molecular events may include changes in gene expression, 
phosphorylation/dephosphorylation of proteins, and molecular exchange between 
intracellular and extracellular spaces. The subcellular events can be changes in 
endocytosis/exocytosis, cytoskeleton remodeling, and nuclear deformation. The cross 
talk between the cell and its microenvironment regulate various physiological and 
environmental cues and may cause changes in cell shape and motility, influence 
proliferation, differentiation, apoptosis, affect the morphogenesis of cellular structures 
and cell migration in tumor metastasis and transformation into malignant phenotypes 
[Elliot, 2010; Talukdar, 2011]. The surrounding cells such as fibroblasts, endothelial 
cells, immune cells, neurons and others together with ECM are active participants in 
shaping the tumor (Figure 2) [Birgersdotter, 2005]. The significance of tumor 
microenvironment, which can be described as the “soil” of cancer cells, has been 
emphasized, especially the cancer-stroma interaction, which has become critical 
determinants of cancer behavior [Chen, 2012]. Malignant tumor cells recruit or activate 
the local vasculature and stroma through production and secretion of stimulatory growth 
factors and cytokines. [Birgersdotter, 2005] The stromal elements affect many different 
aspects of cancer cell behavior, including the cell’s proliferation rate and resistance to 
drug-induced apoptosis [Burdett, 2010]. Functional studies in various cancer types, 
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including breast, colon, prostate, lung and pancreatic cancer, have confirmed the concept 
that fibroblasts can determine the fate of epithelial cells, since they are able to promote 
malignant conversion as well as to revert tumor cells to a normal phenotype 
[Birgersdotter, 2005]. 
 
Fig.2) Tumor mass with stroma: showing the major supporting non-cancer stromal cells and 
pivotal protein families [Nyga, 2011]. 
1.1.2.2 Significance of 3D cell culture 
The vast majority of in vitro tumor biology studies are still performed using monolayer 
cultures even though such suboptimal study systems might result in misleading research 
observations and hypotheses [Hutmacher, 2010]. However, a small yet growing number 
of cancer researchers, aware of the limitations of conventional 2D monolayer cell 
cultures, are moving towards the use of 3D cell culture systems to understand that the 
microenvironmental cues found in the ECM of the local cell niche, and that from other 
surrounding cells, are equally as important as the cell itself [Ingber, 2008]. A substantial 
amount of evidence demonstrated important differences in the behavior of cells grown in 
monolayer and in 3D cultures. Although cell lines are often used as substitutes for 
tissues, it is obvious that cell lines only approximate properties of normal and tumor 
tissues. Moreover, this approximation is limited to the malignant cell and does not take 
into account the impact of the tumor stroma [Birgersdotter, 2005]. A major limitation of 
2D monolayers is their lack of stroma, this being important when modelling human 
cancer such as breast cancer as stroma of the mammary gland accounts for greater than 
80% of the resting breast volume [Kim, 2005]. These stromal elements affect many 
different aspects of cancer cell behavior, including the cell’s proliferation rate and 
resistance to drug-induced apoptosis [Burdett, 2010]. Recently, it has been shown that 
3D-cultured tumor cells display different metabolic characteristics compared to those 
cultured in only 2D monolayers. A predominant feature of these 3D cultured cells is their 
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increased glycolysis, as detected by the production of high levels of lactic acid [Evenou, 
2009]. A number of studies found differences in drug sensitivity between 2D and 3D 
cultures both for single drugs and drug combinations [Bissel, 2001; Kimlin, 2011]. 
Shang-Fong et al. showed that Ewing sarcoma cells cultured in 3D scaffolds not only 
were more resistant to traditionally cytotoxic drugs than cells grown in 2D monolayer 
culture, but also exhibited remarkable differences in the expression pattern of insulin 
pathway [Shang-Fong, 2013] Compared to 2D-cultured tumor cells, cells from a 3D 
culture also display a decreased sensitivity to apoptosis as induced by radiochemical 
treatment or by death receptor ligation [Yang, 2007]. As a 3D structure, a scaffold has 
the potential of recapitulating the native geometry, unlike 2D cell monolayer (Figure 3). 
3D scaffolds represent the goal to better understand tumor progression, metastasis and 
provide a tool for screening therapeutics in vitro. 3D culture systems are designed to 
bridge the gap between in vitro and in vivo cancer models by retaining the in vivo 
phenotype through mimicking the structure of the tumor microenvironment. Thus, from 
a biological point of view, cancer cells cultured in 3D reveal a number of characteristics 
that sets them apart from monolayer cultures, and that more closely resemble those 
observed in tumors in vivo. Hence, increasingly, 3D models will be the preferred 
approach to assess tumor cell biology in vitro. 
 
Fig.3) A schematic diagram depicting a) a 2D cell culture on plastic; b) a 3D cell culture in a 3D 
model; c) in vivo tumor growth with supporting stromal cells [Nyga, 2011]. 
1.1.2.3 Features of tumor cells cultured in 3D structures 
3D cultures have been used for a long time to study morphogenesis and tissue formation 
in vitro in conditions better controlled than in vivo models. More recently, these methods 
have also been applied to the analysis of malignant transformation and tumor progression 
[Fischbach, 2007]. In particular, regarding breast cancer, the invasion of the glandular 
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lumen, a typical feature detectable in the initial phases of the development of these 
tumors, has been successfully reproduced in vitro, and its mechanisms have been 
explored in detail thanks to the use of 3D cultures [Bissel, 2005; Bentires-Ali, 2006]. 
Cancer cells cultured in 3D are characterized by several peculiar features and paralleling 
those of in vivo tumors. In particular, early events of tumor growth before effective 
vascularization appear to be closely reproduced. Indeed, within a short timeframe, 3D 
cultures of tumor cells develop hollow cores that resemble the necrotic areas of in vivo 
cancers: areas that are usually observed at a distance from nutrient and oxygen supplies 
[Feder-Mengus, 2008]. Tumor cells of epithelial origin cultured in 3D have also been 
shown to change shape and lose polarity, a feature typically associated with tumor 
progression in vivo [Yamada, 2007]. Polarity also plays a role because oncogene-induced 
disruption of acinar architecture requires interaction with polarity complex components. 
This interaction between oncogene and polarity signaling induces acinar disruption while 
suppressing apoptosis independently from oncogene stimulation of proliferation 
[Aranda, 2006]. 
Cancer cells cultured in 3D display features largely overlapping with those of cells 
cultured in spheroids, a small, tightly bound cellular aggregate that tends to form when 
transformed cells are maintained under nonadherent conditions. These cellular 
aggregates can range in size from 20 mm up to 1mm in diameter, depending on the cell 
type and growth conditions. Spheroids have been widely used in cancer research because 
the 3D architecture and extensive cell–cell contacts provided by spheroid growth appear 
to better mimic the in vivo cellular environment than 2D monolayer cultures. Spheroids 
also exhibit many of the biological properties of solid tumors, including cell 
morphology, growth kinetics, gene expression, and drug response [Burdett, 2010]. 
Spheroids can be studied in 3D matrices and they can be established from a single cell 
type or can be multicellular mixtures of tumor, stromal and immune cells. Multicellular 
spheroids development, which could resemble cancerous tissues in terms of structural 
and functional properties (Figure 4) [Lin, 2008], usually contains both surface-exposed 
and deeply buried cells, proliferating and non-proliferating cells and well-oxygenated 
and hypoxic cells [Frieboes, 2006]. Homogeneous populations of spheroids may prove 
valuable for high-throughput drug screening [Kunz-Schughart, 2004]. Spheroids can also 
be used to study the adhesive properties of tumor cells [Winters, 2005], and their 
behavior can be analyzed by computational modeling [Frieboes, 2006]. 
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Fig.4) Schematic overview of the in vivo tumor and in vitro tumor spheroid [Phung, 2011]. 
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1.2 Design of Scaffolds for Cancer Research 
Advances in tissue engineering have traditionally focused on the design of scaffolds-
based culture systems and models that reflect as closely as possible the biological, 
physical and biochemical environment of the natural extracellular matrix (ECM). 
Although clinical applications based on tissue engineering concepts, such as the 
replacement of body tissues, attract most of the media attention, it is clear that other 
fields of medical research could be enhanced by the powerful and modular tools already 
developed in tissue engineering. Three-dimensional (3D) in vitro tissue engineering 
models that are designed to resemble the physiology of tissues could be used to study 
disease pathogenesis of tumors [Hutmacher, 2009a]. Histopathologic analysis shows that 
malignant cancer cells are surrounded by the stroma, or tumor microenvironment that 
can account for a large proportion of the tumor. This surrounding tumor 
microenvironment is composed of ECM and several cell types. It is now well appreciated 
that the stroma is not a bystander but actively participates in tumor progression 
[Froeling, 2010]. 3D tissue culture models have an invaluable role in tumor biology 
today providing some very important insights into cancer biology. They provide a well-
defined environment for cancer research recapitulating the native geometry, unlike two-
dimensional (2D) cell monolayer cultures and the complex host environment of an in 
vivo model. Increased use of 3D models that mimic specific tissues should promote 
advances in tissue engineering and could also facilitate the development and screening of 
new anticancer therapeutics [Yamada, 2007]. 
1.2.1 Scaffolds requirements 
Tissue engineers have focused on developing scaffolds that can mimic key features of 
ECM, and at the same time provide the possibility of flexibly altering their physical and 
biochemical characteristics. Well-defined and characterized biomaterials-based tissue 
engineering platforms are appealing because they offer batch-to-batch uniformity with 
improved, controllable and reproducible architecture, degradation rates and mechanical 
properties [Hutmacher, 2010]. Several reviews and research articles [Hutmacher, 2009b] 
have accurately summarized and demonstrated that conditions and characteristics of the 
3D microenvironment significantly influence and control tumorogenesis. 3D models, in 
principle, reflect the distinct invasive behavior of human tumor cells, mimic the tumor–
stromal cell interactions of human carcinomas and allow for systematic investigation into 
the multiple unknown regulatory feedback mechanisms between tumor and stromal cells 
in a well-defined 3D environment [Kim, 2005]. The biological cross talk between cells 
and the scaffolds is controlled by the material properties and scaffold characteristics. In 
order to induce cell adhesion, proliferation, and activation, materials used for the 
fabrication of scaffolds must possess several requirements. Ideally, a scaffold should be 
biodegradable at a rate matching ECM deposition so that no residual polymer is left. It is 
also necessary that scaffolds do not form any product(s), which may interfere with cell 
growth [Sahoo, 2005]. Macro and microstructural properties affect not only cells 
survival, signaling, growth, propagation and reorganization, but play also a major role in 
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modeling cell shape and gene expressions, both related to cell growth and preservation of 
native phenotypes [Leong, 2003]. Scaffold should possess an interconnected and spread 
porosity with a highly porous surface and microstructure. Pore interconnectivity directly 
influences the diffusion of physiological nutrients and gases to cells as well as the 
removal of metabolic waste and by-products from cells. The scaffold should have 
sufficient mechanical strength during in vitro culturing to maintain the spaces required 
for cell ingrowth and matrix formation. Recently, several studies reported that the 
scaffold mechanical rigidity plays a pivotal role in regulating the malignancy of cancer 
cells adhered to the surfaces, affecting intercellular organization and malignancy [Liang, 
2011]. 
1.2.2 Natural polymers commonly used in 3D cancer cell cultures 
A great number of different natural materials have been studied and proposed for the 
preparation of scaffolds in tissue engineering and regenerative medicine. Economic and 
environmental aspects are contributing to the growing interest in natural polymers, due 
to their low toxicity, low manufacture costs, low disposal costs and renewability 
[Shogren, 1999]. Natural polymers derived from algal origin such as alginate, or derived 
from animal origin such collagen, hyaluronic acid, silk protein have been the most 
commonly used for tissue engineering application, especially for cancer research [Zhang, 
2005; Desai, 2006; Gurski, 2009; Loessner, 2010]. A brief description of their main 
physical-chemical features and applications is reported by following. Moreover, in the 
following section, chitosan and poly(γ-glutamic acid) (γ-PGA) (derived from animal and 
bacterial fermentation, respectively) employed for the preparation of 3D scaffolds in the 
present thesis, will be discussed. 
Alginate 
Alginates are produced by brown seaweeds, and are linear unbranched polymers 
containing β-(1–4)-linked D-mannuronic acid (M) and α-(1–4)-linked L-guluronic acid 
(G) residues. Although these residues are epimers, they possess very different 
conformations. Alginates are not random copolymers but, according to the source of 
algae, consist of blocks of similar and strictly alternating residues (i.e., MMMMMM, 
GGGGGG and GMGMGMGM), each of which has a different conformational 
preference and behavior. Alginates may be prepared with a wide range of average 
molecular weights (50–100,000 residues) to suit the specific application [Draget, 1997]. 
As a macromolecule of natural origin, alginate has been used as a scaffold material 
[Hutmacher, 2001]. Recent studies demonstrated how MCF-7 cell (derived from human 
breast cancer) were able to form single multicellular tumor spheroids after 5 days of 
cultivation when encapsulated in alginate-poly-L-lysine-alginate microcapsules. This 
result suggested that multicellular tumor spheroids have the potential to be rapid and 
valid in vitro models, useful in the screening of chemotherapeutic drugs and mimicking 
in vivo cell growth patterns [Zhang, 2005 reviewed by Xu, 2007]. 
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Collagen 
Among all natural polymers, collagen has been the most widely investigated. Collagen is 
a biological protein, with a high content of glycine (Gly) (near 33%) and of imino acids 
(near 20%), abundant in the ECM of many tissues (skin, bone, cartilage, tendons, blood 
vessels, teeth), where it provides the principal structural and mechanical support [Lee, 
2001]. Gly is present in the polypeptide chain as every third residue, forming a (Gly-X-
Y)n repeating pattern which adopts a left-handed helical structure (α chain) longer than 
1400 aminoacids and with three residues per turn. The most common tripeptide sequence 
found in collagen is composed of Gly, proline (Pro) and hydroxyproline (Hyp) (Gly-Pro-
Hyp). Three α chains wrap around one another with a right-handed twist, in a tightly 
packed triple helix. The collagen fibrils are stabilized by specific covalent crosslinks 
between collagen molecules [Brodsky, 2003]. Collagen is the major component of 
mammalian connective tissue, and is found in every major tissue that requires strength 
and flexibility. Collagen matrices may be designed with a porous structure, thereby 
providing three critical functions for the scaffold. First, pores and channels can allow the 
migration or entry of cultured cells into the scaffold. Second, the porous structure can 
give the scaffold an enormous surface area for cells to adhere to and interact with the 
scaffold. Third, the porous structure can allow nutrients to diffuse into the scaffold to 
support the growth of the seeded cells [Xu, 2007]. Collagen scaffolds comprise a random 
mesh of collagen fibrils supporting a large amount of excess fluid (99%). A major 
drawback of such scaffolds is their very low density, which does not mimic the naturally 
stiff environment in which tumor cells, and most tissue cells, naturally reside. The 
stiffness of collagen scaffold affects cell growth and their morphology [Paszek, 2005]. 
Hyaluronic acid 
Hyaluronic acid (HA), a linear high molecular mass polysaccharide, is most frequently 
referred to as hyaluronan because it exists as a polyanion and not as free acid. It consists 
of alternating disaccharide units of α-1,4-D-glucuronic acid and β-1,3-N-acetyl-D-
glucosamine with a molecular weight ranging from 103 to 107 [Laurent, 1995]. HA is 
highly expressed in malignant tumors, making it an integral component of the 
microenvironment of bone metastatic cancer cells [Bharadwaj, 2009]. Gurski and 
coworkers demonstrated that in HA hydrogels, prostate cancer cells adopt a rounded, 
clustered morphology reminiscent of tumor tissue in vivo. Thus, HA-based covalently 
cross-linked 3D hydrogel matrices are attractive candidates for in vitro investigation of 
novel therapeutics targeting osteoblastic prostate cancer cells [Gurski, 2009]. 
Silk protein 
Silk protein isolated from the silkworm Antheraea mylitta exhibits promising properties 
as a biomaterial. Silk protein fibers have great tensile and mechanical strength and high 
elasticity. The greater mechanical strength and elasticity of Antheraea mylitta fibroin 
makes it suitable for a variety of applications such as long term cell culture, where 
durability of the matrix is very important. Fibroin isolated from the silkworm has been 
studied as a biocompatible matrix for cell attachment and viability of fibroblasts, 
differentiation of osteoblasts, human dermal fibroblast cell proliferation and migration, 
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osteogenic differentiation of human mesenchymal stem cells and rat bone marrow 
stromal cells [Talukdar, 2011]. Silk protein polymer scaffolds provide a biocompatible 
3D microenvironment for cell attachment, growth and tissue formation, are easy to 
reproduce, convenient to handle, and amenable for large-scale use [Talukdar, 2011]. 
Chitosan 
The history of chitosan dates back to the 19th century, when Rouget [Dodane, 1998] 
discussed the deacetylated forms of the parent chitin natural polymer in 1859. During the 
past 20 years, a substantial amount of work has been reported on chitosan and its 
potential use in various bioapplications. Chitosan molecule is a copolymer composed of 
N-acetyl-D-glucosamine and D-glucosamine units available in different grades 
depending upon the degree of acetylated moieties [Hsieh, 2005] (Figure 5). It is a 
polycationic polymer that has one amino group and two hydroxyl groups in the repeating 
glucosidic residue. 
 
Fig.5) Representative chemical structure of chitosan. 
Thus, chitosan is a copolymer consisting of N-acetyl-2-amino-2-deoxy-D-glucopyranose 
and 2-amino-2-deoxy-D-glucopyranose, where the two types of repeating units are 
linked by (1→4)-ß-glycosidic bonds. After refinement, chitosan has a rigid crystalline 
structure through inter- and intra-molecular hydrogen bonding [Dash, 2011]. The source 
of chitosan is a naturally occurring polymer, chitin, that is the second most abundant 
polysaccharide in nature, cellulose being the most abundant. Chitin is found in the 
exoskeleton of crustacea, insects, and some fungi. Due to chitin’s poor solubility in 
aqueous solution and organic solvents, it does not find practical applications whereas 
chitosan as an artificial variant of chitin is more suitable for useful bioapplications. 
Chitosan is obtained by the thermochemical deacetylation of chitin in the presence of 
alkali and naturally it occurs only in certain fungi (Mucoraceae). Several alkaline 
methods have been proposed, most of them involving the hydrolysis of the acetated 
position using sodium or potassium hydroxide solutions as well as a mixture of 
anhydrous hydrazine and hydrazine sulfate [Chatelet, 2001]. The treatment of chitin with 
an aqueous 40–45% (w/v) NaOH solution at 90–120 °C for 4–5 h results in N-
deacetylation of chitin. The conditions used for deacetylation determines the polymer 
molecular weight and the degree of deacetylation (DD). The active primary amino 
groups on the molecule being reactive provide sites for a variety of side group 
attachment employing mild reaction conditions (Figure 6). Because the free amine 
groups of chitosan become protonated in acidic environments, the positively charged 
polymer is soluble at low pH [Sashiwa, 2004]. The net positive charge of chitosan in 
acidic environments allows the formation of polyelectrolyte complexes (PECs) with 
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polyanionic species [Rinaudo, 2008] (an overview on PECs is reported in following 
paragraph § 1.2.3.1). 
 
Fig.6) Schematic illustration of chitosan’s versatility. At low pH (less than about 6), chitosan’s 
amine groups are protonated conferring polycationic behavior to chitosan. At higher pH (above 
about 6.5), chitosan’s amines are deprotonated and reactive. 
In recent years, a considerable literature has been published on the investigation of the 
possibility to develop and standardize 3D material scaffolds to create an artificial 
structure that can mimic the in vivo tumor microenvironment, which could be used as a 
platform for more representative in vitro study and screening of therapeutics [Caicedo-
Carvajal, 2012; Hutmacher, 2009a]. In this sense, there has been a growing body of 
literature exploring chitosan polymeric scaffolds for 3D growth of cancer cell lines. 
Scaffolds prepared from natural polysaccharides, such as chitosan, are promising for 
mimicking the in vivo tumor ECM since they resemble glycosaminoglycans (GAGs), 
which are essential components of the ECM. Chitosan scaffolds of varying degrees of 
deacetylation were prepared for 3D growth of MCF-7 breast cancer cell lines by Panda 
and coworkers [Dhiman, 2004]. The degree of deacetylation is a structural parameter, 
which influences physicochemical properties such as the molecular weight, the 
elongation at break and the tensile strength. It also influences biological properties such 
as cell adhesion by influencing the ability of the substratum to adsorb protein and/or by 
altering the conformation of the adsorbed protein. Panda et al. revealed that prolonged 
exposure of cells to chitosan scaffold did not result in cell death or change in 
morphological nature. This is in accordance with the excellent biocompatibility of 
chitosan on different cell lines such as hepatocytes [Tan, 2010], chondrocytes [Coimbra, 
2011] and keratinocytes [Correia, 2011]. These results also confirmed that degree of 
deacetylation has very little effect on biocompatibility of chitosan. Chitosan was also 
combined with various other materials like HA and alginate. Recent studies [Florczyc, 
2012] showed that 3D porous chitosan-alginate scaffolds were able to support the growth 
of prostate cancer cells and formation of prostatic cancer tumor spheroids. The same 
research group demonstrated that U-118 MG human glioblastoma multiforme (GBM) 
cells cultured in chitosan-HA hydrogels, promoted tumor spheroid formation and were 
also more resistant to chemotherapy drugs compared with 2D cultures [Florczyc, 2013]. 
Cancer cells grown into a tissue-like structure in a polymeric matrix may closely mimic 
the biology of tumor development in vivo and hence can serve a better model system for 
preclinical evaluation of the cytotoxic effect of anticancer agents. It was expected that, 
due to the 3D nature of cell growth in chitosan scaffolds, the cytotoxicity of anticancer 
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drugs in vitro would be very similar to that observed in in vivo tissue conditions. The 
ease of availability, low cost, simple preparation, and excellent biocompatibility of 
chitosan make it a very attractive substratum for cell culture in vitro. Thus such 3D tissue 
growth models can be used not only for evaluating the anticancer activities of new drugs 
but also for providing information about the regulation of both autocrine and paracrine 
growth factors that control cancer cell growth [Xu, 2007]. 
Poly (γ-glutamic acid) 
Poly (γ-glutamic acid) (γ-PGA) is an anionic polymer composed of thousands of 
glutamic acid residues (1200–12000) linked by γ-glutamyl units that are connected by 
amide linkages between the α-amino and γ-carboxylic groups (Figure 7) [Ho, 2006]. γ-
PGA was first discovered by Ivanovics and coworkers [Ivanovics and Bruckner, 1937; 
Ivanovics and Erdos, 1937] as a capsule of Bacillus anthracis where it plays a relevant 
role in virulence. 
 
Fig.7) Representative chemical structure of γ-PGA. 
γ-PGA is produced predominantly by bacteria belonging to various strains of Bacillus, 
(such as B. anthracis, B. licheniformis, B. subtilis, B. megaterium, B. pumilis, B. 
mojavensis and B. amyloliquefaciens) because of its high productivity and well-studied 
bioprocess development. A halophilic archaebacterium, Natrialba aegyptiaca species 
[Hezayen, 2001] are also known to produce γ-PGA. Recently, effort has been paid to 
produce γ-PGA in some engineered hosts, including Escherichia coli, Coryneform 
bacteria, and even tobacco (however, the productivity was very limited and needs to be 
further improved). Nevertheless, up to now, most research on the production of γ-PGA is 
focused on Bacillus species. B. licheniformis and B. subtilis have been majorly used for 
fermentative production of γ-PGA. It is believed that γ-PGA is synthesized in a 
ribosome-independent manner. Identification and analyses of genes responsible for the 
synthesis of this polymer are extremely important to understand its biosynthetic 
mechanism. Synthesis of highly elongated γ-PGA involves extremely unique mechanism 
[Ashiuchi, 2005]. Biosynthesis of γ-PGA in bacteria is carried out in two steps. In the 
first step, synthesis of L- and D-glutamic acid takes place; where as in second step, these 
D and L-glutamic acid units are joined together to form γ-PGA. The nomenclature for 
the genes involved in γ-PGA synthesis is dependent on whether the synthesized γ-PGA is 
retained or released [Candela, 2005]. If the γ-PGA is associated with the bacterial surface 
and forms a capsule, the genes are named cap (for ‘capsule’). Similarly, the 
corresponding genes are named pgs (for polyglutamate synthase) if the γ-PGA is 
released. In B. anthracis, the genes related to γ-PGA synthesis (capB, capC, capA and 
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capE, encoding a 47-amino-acid peptide) lie on a large plasmid DNA, namely pXO2. 
Organization of cap genes in B. anthracis is illustrated in Figure 8. In contrast, in B. 
subtilis and B. licheniformis, the four pgs genes coding for the formation of γ-PGA 
(pgsB, pgsC, pgsAA, and pgsE) are organized into operons (Figure 8) [Osera, 2009; 
Bajaj, 2011]. 
 
Fig.8) The genetic elements required for γ-PGA synthesis in B. anthracis, B. subtilis and B. 
licheniformis [Bajaj, 2011]. 
As reported by the literature, it is possible to improve productivity and variation in chain 
D/L-repeat unit composition [Bajaj, 2011]. In order to enhance the γ-PGA productivity, 
researchers have investigated the nutrient requirements for γ-PGA production and found 
that the nutrient requirements varied according to the strain used. According to the 
nutrient requirements, γ-PGA producing bacteria are divided into two groups; one 
requires the addition of L-glutamic acid to the medium to stimulate γ-PGA production 
and cell growth, the other does not require L-glutamic acid for γ-PGA production. The γ-
PGA produced by Bacillus species generally has high molecular weight in the range of 
105–106 Da. Most of the molecular weight determinations of γ-PGA have been 
performed by gel permeation chromatography (GPC) using a diversity of mobile phases 
and calibrating against different standards [Shih, 2001]. Park et al. [Park, 2005] 
developed a simple method for determination of the molecular weight of γ-PGA on the 
basis of numbers of glutamate monomers generated by hydrolysis and a free amino 
group quantified with 1-fluoro-2,4-dinitrobenzene (FDNB). The molecular weight 
determination with FDNB was applicable even for a super-high-molecular-weight γ-
PGA. The molecular weight of γ-PGA is dependent on the bacterial strains [Shih, 2001], 
medium components, culture conditions and other unknown reasons. γ-PGA is water 
soluble, biodegradable, edible and not toxic towards human and the environments, hence 
during the past decade, γ-PGA has been proposed for potential applications in wide 
areas, including food, cosmetic, agriculture, sewage treatments, as animal feed 
complements or as natural bactericide. Moreover, the structural conformational states 
and special binding characteristics of the α-carboxilate anionic groups play important 
roles in determining the chemical and biological functionality of the biopolymers. With 
high hydrophilicity and reactivity important for many biological functions, the unusual 
polyanionic properties and structural characteristics are also significant for bioflocculant 
functions and detoxification of heavy metallic ions, and may also represent certain 
activities against pathogenic microbial activity and the growth of tumor cells as well 
[Ho, 2006]. Furthermore, recent studies described γ-PGA as a material with fine swelling 
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ability and biocompatibility, which makes it suitable for use in clinical applications as 
bioglue, drug delivery systems, and tissue engineering [Chang, 2009]. Little has been 
done to explore the use of γ-PGA within tissue engineering, especially in cancer 
research, Since γ-PGA appears to be a good candidate to act as a material for polymer 
scaffold and tissue engineering, it was decided to investigate the possibility of employing 
γ-PGA-combined with various other materials for the preparation of 3D scaffolds for 
long term tissue cultures. 
1.2.3 Engineered hydrogel scaffolds as extracellular matrix mimics 
In vivo cells grow within a complex and bioactive hydrogel scaffold, namely the ECM, 
that provides mechanical support while directing cell adhesion, proliferation, 
differentiation, morphology, and gene expression. ECM is a hydrogel-like structure 
comprised of several different biopolymers, encompassing a wide range of biological, 
chemical, and mechanical properties [Aizawa, 2012]. Biologists and bioengineers have 
investigated many 3D scaffolds that recapitulate aspects of the native cellular 
microenvironment for in vitro cell culture. Among these, hydrogels demonstrate a 
distinct efficacy as matrices for 3D cell culture. Hydrogels are 3D cross-linked insoluble, 
hydrophilic networks of polymers that partially resemble the physical characteristics of 
native ECM. Consequently, they are soft, pliable, wet materials with a wide range of 
potential biomedical applications [Drury, 2003]. Hydrogels can absorb a large amount of 
water or biological fluid (up to 99%) due to the presence of interconnected microscopic 
pores and can provide a good growing environment for soft tissues because [Tsao, 2011]. 
A significant growth of interest in hydrogels rose at the beginning of the 1990s, partly 
due to the rapid emergence of the TE field, as hydrogels possess characteristics of native 
ECM paving the way for functional tissues (Figure 9) [Geckil, 2010]. Hydrogels used for 
cell culture can be formed from a vast array of natural and synthetic materials, offering a 
broad spectrum of mechanical and chemical properties. Recent advantages in biomaterial 
research have enabled engineering of hydrogels to include structure and function found 
in the natural ECM and allow the design and execution of systematic studies in cancer 
biology [Tibbitt, 2009]. In this context, cell-ECM interactions are fundamental to 
carcinogenesis and related signalling events. The possibility of re-creating controlled 
extracellular microenvironments is a key feature of hydrogels that can be exploited to 
study cancer cell-ECM interactions [Loessner, 2010]. Research groups growing cancer 
cells in HA hydrogels, collagen/fibrin gels, surface engineered porous microparticles, 
and fibroblast derived 3D matrices have shown differential drug sensitivity when 
compared to the same cells grown on 2D monolayer culture [Gurski, 2009]. The 
scaffolds must offer properties (i.e., mechanical and chemical) that lead to cellular 
function in a native manner [Geckil, 2010]. The limitation of hydrogel mechanical 
properties is well known, the desired mechanical properties in terms of stiffness and 
tensile strength can be achieved by adjusting various parameters including the type of 
polymers used, their concentrations and the crosslinking density. 
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Fig 9) The total number of publications with ‘tissue engineering’ and ‘hydrogel’ or ‘hydrogels’ in 
the title. The exact numerical values are provided at 5-year intervals (Source: Science Citation 
Index Expanded [SCI-EXPANDED] reviewed by Geckil, 2010). 
1.2.3.1 Physical association networks: polyelectrolyte complexes 
Hydrogels are 3D cross-linked insoluble, hydrophilic networks of polymers that partially 
resemble the physical characteristics of native ECM. Hydrogels are kept from dissolution 
by the presence of radical, chemical, or physical crosslinks. Although radical crosslinks 
provide a high crosslink quality, there is always the possibility of radical residues 
remaining in the hydrogels. The networks of chemical hydrogels are formed by 
irreversible, covalent crosslinking. However, free unreacted covalent crosslinkers are 
potentially toxic, therefore alternative types of networks, formed by direct physical 
interactions between polymer chains without the addition of crosslinkers, have been 
developed [Hennink, 2002]. Several non-covalent modalities have been exploited in the 
design of hydrogels, including, hydrophobic interactions, antigen–antibody interactions, 
stereocomplex interactions, and ionic interactions [Lin, 2005]. For ionic crosslinked 
hydrogels, swelling occurs as a result of ionic interactions between free ions and the 
charged polymer, which may feature carboxylic acid, sulfonic acid, or amino groups. 
The electrostatic attraction between polymers displaying oppositely charged groups give 
rise to the so called polyelectrolyte complexes (PECs). In PECs, the interactions between 
the cationic polymer and the anionic polymer are stronger than other secondary binding 
interactions like hydrogen bonding. This type of ionic complexes avoids the use of 
organic precursors, catalysts, or reactive agents, alleviating the concern about toxicity or 
reactions with a therapeutic payload. Since PECs only consist of cationic and anionic 
polyelectrolytes, their complexation is generally straightforward and reversible 
[Samoilova, 2010]. The structure and properties of PECs hydrogels are similar to those 
of many biological soft tissues. PECs hydrogels are the networked structure of polymer 
chains crosslinked to each other and surrounded by an aqueous solution. PECs networks 
have been produced between chitosan and DNA, chitosan and anionic polysaccharides 
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such as alginate, glycosaminoglycans, chondroitin sulfate, hyaluronic acid, heparin, 
carboxymethyl cellulose, pectin, dextran sulfate, xanthan, proteins such as gelatin, 
albumin, fibroin, keratin, and collagen, synthetic anionic polymers such as (polyacrylic 
acid) and recently also with polyamminoacid such γ-PGA (Figure 10) [Kang, 2006; 
Tsao, 2010; Tsao, 2011; Hsieh, 2005; Singh, 2009]. The stability of these complexes is 
dependent on charge density, solvent, ionic strength, pH, and temperature. The charge of 
the anionic molecule under physiological conditions is an important factor for PECs to 
occur; since the pH of the hydrogel environment modifies the ionic interactions, cell 
culture environment must be considered when using PECs for hydrogels. 
Fig.10) Schematic representation of the ionic interaction formation between chitosan and γ-PGA. 
1.2.4 Techniques for polymeric scaffolds preparation 
Scaffold manufacturing processes should assure a high level of control over macro and 
microstructural properties that meet key requirements of specific application. Depending 
on the fabrication process, scaffolds with different architecture can be obtained, with 
random or tailored pore distribution. Several techniques have been developed to fabricate 
scaffolds. In the following section two different techniques to prepare scaffold employed 
in the development of the present thesis, namely freeze-drying technique and computer-
controlled wet-spinning, will be discussed. 
1.2.4.1 Freeze-drying 
Freeze-drying involves removal of a solvent first by sublimation of a frozen sample and 
then by desorption of the nonfrozen sorbed solvent under reduced pressure. Polymeric 
scaffolds can be prepared by freeze-drying. In the freezing stage, the polymer solution or 
dispersion is cooled down to a temperature where all the material is in a frozen state 
resulting in the formation of ice crystals, forcing the polymer molecules to aggregate into 
the interstitial spaces. In the second phase, the solvent is removed by applying a pressure 
lower than the equilibrium vapor pressure of the frozen solvent. Meanwhile some of the 
unfrozen sorbed water in the dried layer may be desorbed. When the frozen solvent is 
completely sublimated, the process continues by slightly warming the sample, until 
complete dryness is obtained. The sublimation of the ice crystals causes the formations 
of a highly porous sponge (Figure 11) [O’Brien, 2004]. The final pore structure depends 
on the process conditions during fabrication like pH, freezing rate and partial pressure. A 
rapid, uncontrolled quench freezing process leads to non-uniform nucleation and growth 
of ice crystals and consequently to scaffold morphological heterogeneity caused by space 
and time variable heat transfer through the system. Otherwise, significantly more 
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uniform porous scaffolds can be manufactured for tissue engineering applications using a 
constant cooling rate freezing technique. Highly porous and interconnected structures 
with small size pores are typically obtained by freeze-drying [Puppi, 2010]. 
 
Fig.11) Schematic representation of freeze-drying process. 
1.2.4.2 Computer-assisted wet-spinning 
Recent studies showed the possibility to exploit additive manufacturing (AM) technique, 
which can be defined as “the process of joining materials to make objects from 3D 
model data, usually layer upon layer” (ASTM 2010), for the fabrication of 3D scaffolds 
by employing computer-assisted wet-spinning technique [Puppi, 2012]. Briefly, wet 
spinning is a nonsolvent-induced phase inversion technique allowing for micrometric 
polymer fibers production through immersion precipitation. Among the various 
processing techniques for manufacturing fibers employed in biomedical applications, wet 
spinning has been mostly used to produce fibers based on natural polymers, such as 
chitin and chitosan fibers, which cannot be formed by other classical spinning 
techniques. In details, a continuous polymer fiber is produced by precipitation of a 
polymer solution filament in a coagulation bath composed by a nonsolvent with respect 
to the processed polymer. A homogeneous solution filament, composed of polymer, 
solvent and possible additives, solidifies because of polymer desolvation, caused by 
solvent–nonsolvent exchange. This fabrication method does not allow an accurate 
control over scaffold external shape and internal morphology [Puppi, 2011a; Puppi, 
2011b]. In this sense, computer-assisted wet-spinning (Figure 12) offers the possibility to 
produce porous polymeric matrices with reproducible and customized microstructure and 
macroshape representing a significant breakthrough in scaffolds manufacturing. The 
major goal of computer-assisted wet-spinning is to obtain a 3D structure with high and 
interconnected porosity, allowing an enhanced controlled over internal and external 
architecture of microfibrous polymeric scaffolds with high reproducibility. The 
computer-assisted wet-spinning technique was developed in the research group were the 
present thesis has been performed and employed for the development of 3D 
microstructured hydrogels as scaffolds for the in vitro culture of pancreatic cancer cells. 
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Fig.12) Scheme of computer-assisted wet-spinning apparatus: a) layered manufacturing strategy: 
layer composed of parallel fibers was fabricated by depositing the polymeric filament with a 
predefined pattern. b) 3D structures were built up with a layer-by-layer process. 
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1.3 Pancreatic Cancer: the Silent Disease 
Pancreatic ductal adenocarcinoma (PDAC) is generally referred to pancreatic cancer. 
Although other types of pancreatic cancers also occur, more than 90% of pancreatic 
cancers are PDAC. In the Western world PDAC represents the fourth leading cause of 
cancer mortality accounting for 3,5% of all cancer-related death [Krug, 2012]. It is one 
of the most lethal human cancers and continues to be a major unsolved health problem at 
the start of the 21st century. It has been estimated that the disease causes 40000 deaths 
per years in the USA [National Cancer Institute, Annual report 2013]. Although the 
mortality rates of pancreatic cancer vary among countries, over the last 30 years, survival 
from pancreatic cancer has improved only very slightly (5-year survival for patients with 
localized, resectable disease of 15–18%, with a decrease to only 2% in the presence of 
metastatic disease) [Hariharan, 2008]. Epidemiologically, the mortality of this tumor 
entity is nearly identical to its incidence, which has not changed significantly during the 
past 30 years. At the time of diagnosis, only 10-20% of PDAC patients are still 
candidates for surgical resection, which is due to both a high proportion of locally 
infiltrating tumors and early metastasis. Unresectable disease without curative options is 
present in the vast majority and is associated with an extremely poor prognosis. In 
patients with resectable PDAC, surgery is followed by a 6-month- course of adjuvant 
chemotherapy, which is the standard of care for early-stage disease, whereas to the 
majority of patients presenting with metastatic disease, palliative chemotherapy should 
be offered. For patients with unresectable, locally advanced disease, chemotherapy alone 
or chemoradiation are options. The front-line treatment for metastatic pancreatic cancer 
has been adjuvant chemotherapy trials of gemcitabine and gemcitabine-based 
combinational therapy. However, over the past decade, no significant advances in 
efficacy of chemotherapeutic treatment have arisen, and the mean survival rate of those 
who have undergone such treatment has not improved [Long, 2011]. This aggressive 
biology and resistance to conventional and targeted therapeutic agents leads to a typical 
clinical presentation of incurable disease at the time of diagnosis [Hezel, 2006]. Despite 
efforts in the past 50 years, conventional treatment approaches, such as surgery, 
radiation, chemotherapy, or combination of these, have had little impact on the course of 
this aggressive neoplasm. Therefore, only by developing a detailed understanding of the 
molecular biology of pancreatic cancer it will be possible to effectively diagnose, 
prevent, and treat this disease [Li, 2004]. 
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1.3.1 Pancreas physiology: exocrine pancreas 
The pancreas, an organ of endodermal derivation, is the key regulator of protein and 
carbohydrate digestion and glucose homeostasis (Figure 13). 
	  
Fig.13) Anatomy of the pancreas. The pancreas is comprised of separate functional units that 
regulate two major physiological processes: digestion and glucose metabolism. A) Gross anatomy 
of the pancreas demonstrating its close anatomical relationship with the duodenum and common 
bile duct. B) The major components of the pancreatic parenchyma on a histological level. At lower 
right is an islet of Langherhans, the endocrine portion of the pancreas, which is principally 
involved in regulating glucose homeostasis. The asterisk is placed among acini, which are 
involved in secreting various digestive enzymes (zymogens) into the ducts (indicated by the solid 
arrow). C) Photomicrographs of haematoxylin and eosin (H&E) - and immunohistochemical-
stained sections of pancreatic tissue demonstrating the various cell types. (Panel 1) An acinar unit 
in relationship to the duct. (Panel 2) Acinar units visualized with an antibody to amylase are seen 
as brown due to Diaminobenzidine staining. (Panel 3) Islet of Langerhans shown stained with an 
antibody to insulin. (Panel 4) A centroacinar cell showing robust Hes1 staining. (Panel 5) Ductal 
cells (seen here in cross-section) are stained with an antibody to cytokeratin-19. D) 
Representation of an acinar unit showing the relationship to the pancreatic ducts. Also depicted 
are centroacinar cells (arrow), which sit at the junction of the ducts and acini [Hezel, 2006]. 
The exocrine pancreas (80% of the tissue mass of the organ) is composed of a branching 
network of acinar and duct cells that produce and deliver digestive zymogens into the 
gastrointestinal tract. The acinar cells, which are organized in functional units along the 
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duct network, synthesize and secrete zymogens into the ductal lumen in response to cues 
from the stomach and duodenum. Within the acinar units near the ducts are centroacinar 
cells. The endocrine pancreas, which regulates metabolism and glucose homeostasis 
through the secretion of hormones into the bloodstream, is composed of four specialized 
endocrine cell types gathered together into clusters called Islets of Langerhans. Mirroring 
the physiologic and cellular diversity of the pancreas is a spectrum of distinct pancreatic 
malignancies that possess histological and molecular features that recall the 
characteristics of the various normal cellular constituents [Hezel, 2006; Li, 2004]. 
1.3.2 Biology and physiology of pancreatic cancer 
PDAC is an aggressive disease that develops in a relatively symptom-free manner and is 
usually advanced at the time of diagnosis. PDAC is associated with only a few known 
demographic and environmental risk factors and a handful of autosomal dominant 
genetic conditions. Multiple studies have established advanced age, smoking, and long-
standing chronic pancreatitis as clear risk factors; diabetes and obesity also appear to 
confer increased risk. Increased risk has also been documented in relatives of PDAC 
patients, and it is estimated that 10% of PDAC cases are associated with an inherited 
predisposition based on familial clustering [Schenk, 2001; Petersen, 2003]. PDAC 
commonly arises in the head of the pancreas with infiltration into surrounding tissues 
including lymphatics, spleen, and peritoneal cavity, and with metastasis to the liver and 
lungs. Histopathologic analysis shows that pancreatic cancer characteristically is 
surrounded by an intense desmoplastic fibrous stroma or desmplastic reaction associated 
with the tumor that can account for a large proportion (up to 70%) of the tumor mass 
(Figure 14) [Froeling, 2010; Armstrong, 2004]. This surrounding tumor 
microenvironment is composed of extracellular matrix (ECM), and several cell types, 
including an heterogeneous population of fibroblasts and pancreatic stellate cells, smooth 
muscle cells, immune, inflammatory cells, lipocytes and endothelial cells and results in a 
3-fold increase in collagen compared with the normal pancreas. 
 
Fig.14) Histology of pancreatic cancer. A) H&E staining of pancreatic cancer tissue and B) its 
schematic representation demonstrating the strong desmoplastic stroma in pancreatic cancer 
[Froeling, 2010]. 
This is predominantly composed of collagen type I and, to a lesser degree, collagen type 
III, both of which are fibrillar collagens. Fibrillar collagens normally contribute to the 
structural integrity of epithelial organs by providing tensile strength to the interstitial 
matrix, which is separated from epithelial cells by basement membranes. In c
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with other epithelial malignancies, a key and prognostic event in pancreatic cancer is loss 
of basement membrane integrity and invasion of malignant cells into the interstitial 
matrix. This exposes malignant cells to interstitial collagens type I collagen of the 
desmoplastic reaction [Chu, 2007]. Pancreatic stellate cells, a subpopulation of cells in 
the normal pancreas with fibroblast characteristics, have been observed in experimental 
models to respond to pancreatic injury and may contribute to the desmoplastic response 
in the setting of cancer [Jaster, 2004]. Given the extensive stromal reaction seen in 
PDAC, it may be speculated that the microenvironment surrounding the cancer cells 
might be responsible for the highly drug resistant phenotype observed in this disease 
[Krug, 2012]. The pronounced stroma reaction is a natural barrier protecting tumor cells 
against systematically applied drugs and therapy mediating chemoresistance in 
pancreatic cancer. Numerous signaling pathways are known to modulate the stroma 
reaction in pancreatic cancer, among them the Hedgehog (Hh) pathway which has been 
described as major mediator of pancreatic carcinogenesis and tumor progression. The Hh 
pathway, which is known to control cell proliferation and differentiation in developing 
embryos [Ingham, 2001], is over-expressed in many extracutaneous cancers, including 
PDAC. The Hh signaling pathway has been reported to be related to cancer cell mobility, 
migration, and invasion in several types of cancers [Li, 2012]. As in epithelial tumors, 
carcinogenesis develops through accumulation of mutations and genetic lesions leading 
to activation of oncogenes and inactivation of tumor suppressor genes. Among the 
genetic alterations are Ki-RAS oncogene activation and p53 tumor suppressor gene 
inactivation. Deramaudt et al. showed that the combination of these genetic events could 
facilitates pancreatic carcinogenesis, cell migration and invasion. Mutations of the Ki-
RAS oncogene are the most frequent genetic alterations found in premalignant and 
advanced stages of PDAC [Almoguera, 1988; Smit, 1988]. Cooperating genetic 
mutations (HER2/NEU overexpression, CDKN2A/ p16INK4A inactivation, p53 
mutations, SMAD4 mutations, and BRCA2 mutations) are recognized to be necessary for 
progression from pancreatic preneoplastic lesions, termed pancreatic intraepithelial 
lesions (PanINs) (Figure 15) [Deramaudt, 2006]. The frequency of Ki-RAS oncogene 
mutations approaches 100% in early PanIN lesions. PanINs are the most common and 
extensively studied precursor lesions, which are found in the smaller-caliber pancreatic 
ducts. Surveys of pancreas specimens from autopsy studies and surgical resection cases 
have suggested that PanINs are a common finding in older adults, occurring in as many 
as 30% of specimens [Hruban, 2000]. Less common precursor lesions are mucinous 
cystic neoplasms (MCNs) and intraductal papillary muci- nous neoplasms (IPMNs) 
(Figure 15). MCNs are large mucin-producing epithelial cystic lesions that harbor a 
distinctive ovarian-type stroma with a variable degree of epithelial dysplasia and focal 
regions of invasion. IPMNs resemble PanINs at the cellular level but grow into larger 
cystic structures. Furthermore, genes that predispose to pancreatitis are associated with 
increased occurrence of PDAC. McWilliams et al. showed a link between mutations in 
the cystic fibrosis gene (CFTR) and PDAC. Heterozygous CFTR mutations are 
associated with chronic pancreatitis, a known risk factor for PDAC [McWilliams, 2005]. 
Since multiple combinations of mutations can lead to the development of PDAC, disease 
sub-classes may present different survival strategies requiring multiple targeted 
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intervention strategies. The biology of PDAC is thought to be related to mutation and 
inactivation of oncogenes and tumor suppressor genes, as well as abnormalities in 
growth factors and their receptors, which affect the downstream signal transduction 
pathway involved in the control of growth and differentiation [Goggins, 2000]. These 
perturbations confer a tremendous survival and growth advantage to pancreatic cancer 
cells, as manifested by development of invasive and metastatic phenotypes that are 
resistant to all conventional treatments. Metastatic spread of cancer requires multiple 
cellular reprogramming events that result in escape from apoptosis, promotion of 
angiogenesis, and replication and growth independent of a basement membrane. The 
complex cellular mechanisms, which allow an independent rogue cell to establish a 
secondary site of tumor growth, involve cell/ECM and cell/cell interactions, receptor-
mediated signaling, cytoskeletal rearrangements, and altered transcriptional programs 
[Scaife, 2008]. A thorough understanding of the specific cellular and molecular 
mechanisms of PDAC development and progression is required in order to identify early 
detection strategies, preventative measures, and effective interventions [Deer, 2010]. It 
appears clear that a better understanding of the fundamental nature of PDAC is needed to 
prevent progression of the disease after a complete surgical resection and to improve the 
clinical outcome. 
 
Fig.15) Pancreatic precursor lesions and genetic events involved in pancreatic adenocarcinoma 
progression. Pictured are three known human PDAC precursor lesions: PanIN, MCN, and IPMN. 
The PanIN grading scheme is shown on the left; increasing grade (1–3) reflects increasing atypia, 
eventually leading to adenocarcinoma. The right side illustrates the potential progression of 
MCNs and IPMNs to PDAC [Hezel, 2006]. 
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1.3.3 Fascin protein: a novel marker of human pancreatic cancer invasiveness 
PDAC is characterized by an unusual aggressiveness and early occurrence of metastatic 
disease. To this date, the molecular basis of this aggressive behavior remains greatly 
unclear [Chifenti, 2009]. Nevertheless, it is well known that tumor cells transformation is 
associated with phenotypic alterations, including proteins overexpression [Yamada, 
2007]. In particular, fascin protein was one of the identified proteins that has the greatest 
change between pancreatic cancer and normal pancreas samples [Maitra, 2002]. Fascin, 
an actin-bundling protein, is highly expressed in specialized cells that are rich in 
filopodia, such as neurons, glial cells, mature dendritic cells and actively migrating cells, 
such as the endothelial cells of microvessels. Fascin expression is often absent in normal 
epithelial cells, such as the epithelia of the bile duct, urinary bladder, breast, colon, 
ovary, pancreas and stomach. Fascin expression is upregulated in several human 
neoplasms, such as breast, lung, kidney, ovary, prostate and pancreatic cancers [Xu, 
2011]. Fascin overexpression is often correlated with an invasive tumor phenotype, poor 
prognosis and decreased disease free survival. Identification of molecular markers that 
could provide more effective early diagnosis of potentially aggressive tumors could 
represent a potential candidate target for possible therapeutic intervention to block initial 
carcinoma cell migration and invasion [Sun, 2011]. 
1.3.3.1 Fascin structure 
Fascin was discovered in the 1970s as a 55 kDa globular actin-binding protein. It was 
named fascin because of its ability to form tight and stable bundles with F-actin (from 
the latin, fasiculus, a bundle). Fascins have been well-conserved in animal evolution: 
homologues are present in Drosophila, echinoderms and the platyhelminth Schimdtea 
mediterannea. Vertebrates genomes encode three forms of fascin: fascin-1 (also known 
as fascin), which is widely expressed by mesenchymal tissue and in the nervous system 
and is low or absent in adult epithelia; fascin-2, which is expressed by retinal 
photoreceptor cells; and fascin-3, which is testis-specific [Adams, 2004]. Early sequence 
and crystal structure analysis of fascin revealed that it is a member of the β-trefoil fold 
family of proteins and consists of four β-trefoil domains (Figure 16a) [Sedeh, 2010]. 
More recent analysis has shown that each of these β-trefoil domains is comprised of six 
2-stranded β- hairpins. In humans, the gene encoding fascin is located at chromosome 
7p22 and encodes a 493 amino acid (aa) polypeptide that is distinct in sequence from all 
other actin-bundling proteins (Figure 16b). To bundle F-actin, fascin must contain two 
actin-binding sites, one of the actin-binding sites is located at the amino terminus in the 
first β-trefoil domain between aa33–47, and the other lies between aa277–493 (Figure 
16b). The recent structural analysis implicated that the N and C termini constitute one of 
the actin-binding sites with both termini located in the same cleft. Another interaction of 
fascin-1 is with the cytoplasmic domain of the p75 neurotrophin receptor (p75NTR). 
This binding depends on the third and fourth β-trefoil domains. A stretch of residues 
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(29–42) at the N-terminus has similarity to an actin-binding site of MARCKS 
(myristoylated alanine-rich C-kinase substrate) and also faces the trefoil 1–4 cleft 
suggesting that this cleft represents one of the actin-binding sites [Jayo, 2010]. In 
addition, fascin binds to a small number of other proteins that can regulate activity or 
function. The best characterized of these is Protein Kinase C (PKC, α and γ isoforms) 
that binds to and phosphorylates fascin at serine 39 within the N-terminal actin-binding 
domain resulting in the loss of actin bundling by fascin [Adams, 2004]. 
 
Fig.16) Fascin structure: a) the structure of the first β-trefoil fold of fascin. β strands are shown in 
blue, coils in green and Ser-39 in red [Kureishy, 2002]; b) schematic representation of fascin 
binding partners and the domains involved on interactions [Jayo, 2010]. 
1.3.3.2 Fascin: role in the regulation of cell adhesion, migration and invasion 
One essential characteristic of metastatic cancer cells is enhanced motility, which 
facilitates the infiltration of metastatic cells into lymphatic and blood vessels and 
extravasation out of the circulation. The forces that drive tumor cell migration and 
invasion are provided by the actin cytoskeleton underlying the critical membrane 
protrusions in migrating tumor cells. To efficiently drive the formation of membrane 
protrusions, it is crucial to cross-link actin filaments into bundles as individual actin 
filaments are flexible. Cross-linking by bundling protein provides the essential rigidity to 
counter the compressive forces from the plasma membrane [Mogilner, 2005]. Fascin is 
an actin-binding protein that functions in organizing two different forms of actin-based 
structures: cortical actin bundles within cell protrusions and cytoplasmic microfilament 
bundles. Whereas cortical actin formation plays a role in cell interaction and migration, 
the cytoplasmic actin bundles contribute to the cytoarchitecture of cells and to 
intracellular movements [Peraud, 2003]. In normal human tissues, fascin is expressed in 
vascular endothelial cells, neuronal cells, and fibroblasts as well as dendritic cells but 
absent in normal and stratified terminally differentiated epithelial cells. It is believed that 
fascin facilitates tumor metastasis by promoting the formation of invasive membrane 
protrusions. Because cell motility is based on rearrangement of the actin cytoskeleton 
and this process of rearrangement is governed by multiple actin-binding proteins, recent 
studies postulated that fascin may play some role in the invasion and metastasis of 
PDAC. In many cell types, protrusions take the form of finger-like extensions (filopodia) 
or broad zones of the plasma membrane (lamellipodia) [Adams, 2001]. Filopodia are 
considered to have multiple roles in cell migration: as sensors of the external 
microenvironment that can determine the direction of migration, and as plasma 
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membrane extensions that form initial contacts with ECM that lead to the generation of 
tractional force to move the cell body forward. Lamellipodia provide more persistent 
protrusions over a wider surface and, in the forms of so-called invadopodia or 
pseudopodia, are also implicated in migration within three-dimensional ECM [Yosuke, 
2005]. The malignant conversion of epithelial cells involves a phenotypic switch to a 
migratory state that enables tumor invasion beyond the basement membrane and 
metastasis. The process of cell migration is poorly understood in epithelial cells, but 
studies in many types of carcinoma cells have documented increased formation of cell 
protrusions at cell margins, release of cell-cell contacts, and group movement of sheets 
of cells [Jawhari, 2002]. Cancer cell adhesion and migration are distinct but related 
events in the process of cancer progression. Cell migration is a complex, cyclical process 
that involves highly coordinated regulation of protrusions and initial adhesions at the 
leading edge and additional cytoskeletal and adhesive structures in the cell body and 
trailing edge. In response to an external, chemoattractant signal, cells become anteriorly-
posteriorly polarised and extend protrusion(s) in the direction of the signal [Yosuke, 
2005]. Cell–ECM adhesions then attach the protrusions to the substratum on which the 
cell is migrating. These adhesions serve as traction points for migration and also initiate 
signals that regulate adhesion dynamics and protrusive activity. Cell contraction through 
actomyosin stress fibers generates tensile force against the adhesions to move the cell 
body forward. Release of ECM-attachments at the rear as the cell moves forward 
completes the cycle [Lauffenburger, 1996]. In this sense, fascin bundles F-actin into well 
ordered parallel bundles, with an 8 nm spacing of the filaments [Kureishy, 2002]. 
Parallel actin bundles are important elements for strengthening the actin cytoskeleton to 
support outward extension of the plasma membrane in cell protrusions at the leading 
edge of migratory cells (Figure 17). Recent studied [Hashimoto, 2007; Chen 2010; 
Vignjevic, 2007] showed that knockdown of fascin expression inhibited tumor cell 
migration and invasion in vitro and decreased tumor metastasis in mouse models. 
Moreover, ectopic expression of fascin promoted tumor cell invasion and metastasis. The 
causal role of fascin overexpression in tumor metastasis is well established; however, the 
molecular mechanisms underlying elevated fascin level in metastatic tumors are not 
clear. Xu et al. explained that in fascin-overexpressing cells, there were more membrane 
protrusions, and the actin filaments were arranged as bundles in the cytoplasm which 
protruded into the membrane projections. Thus, it seems likely that the rearrangement of 
the actin cytoskeleton induced by fascin overexpression in pancreatic cancer cells 
promoted their motility and invasion, which resulted in a more aggressive phenotype 
[Xu, 2011]. The mechanisms by which fascin is overexpressed in tumors are not clear 
[Sun, 2011]. It is not yet known whether the molecular basis for increased fascin protein 
expression by carcinomas is transcriptional or post-transcriptional, or whether the same 
mechanism is involved in carcinomas of different origins [Yosuke, 2005]. 
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Fig.17) Cartoon of fascin localisation in cells and association with F-actin structures [Jayo, 
2010]. 
1.3.4 Cytokines involved in pancreatic cancer metastatic behavior 
Most solid tumors are surrounded by a variety of non-tumor cells, including stromal 
cells, immune cells, and blood-vessel cells, which are critical components in 
inflammation. Although the functional link between inflammation and pancreatic cancer 
has not been elucidated, several studies have shown the involvement of inflammatory or 
proinflammatory mediators (cytokines) in cancer development and aggressiveness 
[Joshita 2009; Feurino, 2007; Schmid, 2011]. Cytokines are a vast and diverse group of 
glycosylated peptides produced by virtually all nucleated cells in human body, and play 
important roles in regulating cell growth, inflammation, and tumor metastasis. From the 
recent literature, it is known that the overexpression of cytokines is correlated to cancer 
aggressiveness, metastatic potential and modulation of tumor-associated neoangiogenesis 
[Waugh, 2008; Liang, 2010]. Tumor growth and spread of tumor cells requires 
angiogenesis [Hendriksen, 2008], in this sense malignant tumor cells recruit or activate 
the local vasculature and stroma through production and secretion of stimulatory growth 
factors and cytokines [Birgersdotter, 2005]. Research into these mechanistic studies has 
led to a growing area of interest in the role of cytokines in PDAC progression, in 
particular the creation of a favorable tumorigenic conditions and aggressively resistant 
metastasis [Feurino, 2006]. The identification of specific biomarkers to provide more 
effective early diagnosis of PDAC could provide insights to new therapeutic target for 
inhibition of tumor progression. 
1.3.4.1 Chemotactic stimuli: tumor-associated neoangiogenesis and metastasis 
One of the characterizing features of pancreatic cancer is its rapid and aggressive 
metastatic behavior, and research into the pathways behind this action strongly 
implicates the involvement of overexpression of some cytokines [Li, 2012]. Cytokines 
are an incredibly complex field of interacting molecular signals, further clouded by the 
fact that cytokines often aid in the regulation of other cytokines and growth factors in 
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multiple signal cascades. The detailed mechanism of how cytokines are involved in 
pancreatic cancer growth, how cytokines interact with other genetic mutations and how 
multiple cytokines interact with each other in pancreatic cancer pathogenesis have not 
been elucidated [Coussens, 2002]. Genetic and functional experiments indicate that 
macrophages, neutrophils, mast cells, eosinophils and activated T cells contribute to 
malignancies by releasing extracellular proteases, pro-angiogenic factors and 
chemokines. Macrophages produce a number of potent angiogenic and lymphangiogenic 
growth factors, cytokines and proteases, all of which are mediators that potentiate 
neoplastic progression. As will be discussed in the following sections, a number of 
studies investigated the role of inflammatory cytokines, chemokines and growth factor as 
“activator” of signal pathways controlling aggressive cell growth such as tumor 
associated neoangiogenesis and metastasis. 
Vascular endothelial growth factor (VEGF) is an important mediator of angiogenesis 
especially in cancer tissue. Elevated levels of VEGF are associated with an increased 
metastatic capacity of tumor cells through increased angiogenesis and stimulation of the 
development of the lymphatic system [Hendriksen, 2008]. Besides induction of cell 
proliferation and migration, VEGF may also play a role in cell survival through autocrine 
functions. Tumor cells secrete VEGF under stressed conditions as hypoxia, radiotherapy 
and chemotherapy. These elevated levels of VEGF in tumor tissue are associated with a 
poor response to treatment and thus poor prognosis [Carmeliet, 2005]. Tang et al. 
showed that VEGF is involved in the activation of different signal pathways 
(phosphatidyl inositol kinase, PI3-Kinase pathway and Akt/protein kinase B 
phosphorylation via the VEGFR-2 receptor) [Tang, 2004] implicated in cancer cell 
proliferation, growth and metastasis of many tumors including PDAC. 
Interleukin 6 (IL-6) is a well studied proinflammatory cytokine with numerous links to a 
variety of malignancies. IL-6 is noted to be overexpressed in PDAC [Bharadwaj, 2007]. 
Studies indicated that IL-6 is induced under hypoxia conditions in PDAC and promotes 
angiogenesis and metastasis, particularly through the upregulation of VEGF [Masui, 
2002]. 
Interleukin 8 (IL-8) it is considered an important component of the tumor 
microenvironment. Tumor-derived IL-8 has the capacity to exert profound effects on the 
tumor microenvironment. For example, secretion of IL-8 from cancer cells can enhance 
the proliferation and survival of cancer cells through autocrine signaling pathways. In 
addition, tumor-derived IL-8 will activate endothelial cells in the tumor vasculature to 
promote angiogenesis and induce a chemotactic infiltration of neutrophils into the tumor 
site. Although IL-8 can promote cell invasion and migration, the capacity of IL-8 to 
induce tumor-associated macrophages to secrete additional growth factors will further 
increase the rate of cell proliferation and cancer cell invasion at the tumor site. The 
multiple effects of IL-8 signaling upon different cell types present within the tumor 
microenvironment suggests that targeting of CXC-chemokine signaling may have 
important implications to halt disease progression and assist in sensitizing tumors to 
chemotherapeutic and biological agents (Figure 18) [Waugh, 2008]. Many studies 
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[Matsuo, 2009] have revealed that PDAC highly produces IL-8, which can promote 
angiogenesis and invasion of tumors. Chen et al. through in vivo analysis showed that 
IL-8 would be a sensitive marker in predicting prognosis and monitoring disease 
progression of the pancreatic cancer patients [Chen, 2012]. 
 
Fig.18) The role of IL-8 signaling in the tumor microenvironment [Waugh, 2008]. 
Macrophage migration inhibitory factor (MIF) has been implicated as a contributor to 
tumor growth and progression through its effects on tumor vascularization and alteration 
of apoptotic signalling pathways. With regard to tumorigenesis, MIF overexpression has 
been linked to an increase in tumor incidence and aggression in a variety of cancers. MIF 
influences several important biological mechanisms and processes by which tumors 
thrive and spread. MIF expression positively correlates with angiogenic growth factor 
expression, microvessel density and tumor-associated neovascularisation [Onodera, 
2009]. Moreover MIF has recently been shown to contribute to tumoral hypoxic 
adaptation by promoting hypoxia-induced factor (HIF-1α) stabilization. MIF influences 
both hypoxic and normoxic neovascular processes within a tumor’s microenvironment 
(Figure 19). Hypoxia is a strong regulator of MIF expression and secretion, suggesting 
that hypoxia-induced MIF acts as an amplifying factor for both hypoxia and normoxia-
associated angiogenic growth factor expression in human malignancies [Rendom, 2009]. 
PDAC has been shown to contain significantly higher levels of MIF message and protein 
than their non-cancerous cell counterpart [Winner, 2007]. Several studies report that MIF 
expression closely correlates with tumor aggressiveness and metastatic potential, 
suggesting an important contribution to disease severity and survival by MIF [Rendom, 
2009]. 
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Fig.19) Scheme demonstrating hypoxic/normoxic contributions to tumor microenvironmental 
adaptation by MIF [Rendom, 2009]. 
Granulocyte colony-stimulating factor G-CSF is recognized as a naturally occurring 
glycoprotein that stimulates the proliferation and maturation of precursor cells in the 
bone marrow into fully differentiated neutrophils. Neutrophils can not only promote 
tumor destruction, but also increase the growth of tumor cells. Moreover, the idea that G-
CSF may not always be beneficial to the host is supported by the findings that G-CSF is 
aberrantly expressed by diverse human tumors, including PDAC [Joshita, 2009]. 
Bharadwaj et al. showed that pancreatic cancer cells, represented by pancreatic cancer 
cell line BxPC-3, release high levels G-CSF [Bharadwaj, 2007]. In fact, solid 
malignancies are sometimes accompanied by leukocytosis and other leukemoid 
symptoms, the mechanism of which is attributed to the production of G-CSF by the 
tumor cells themselves. G-CSF-producing tumors exhibit significant hyperplastic and 
metastatic properties and have a very poor prognosis [Kobajashy, 2012], due to the 
effects of G-CSF on proliferating tumor cells and enhancement of metastasis. G-CSF 
may therefore accelerate the clinical progression of the disease [Joshita, 2009]. 
Stromal-derived factor-1α (SDF-1α) is a chemotactic factor for T cells, monocytes, 
hematopoietic progenitor cells, endothelial cells, and tumor cells [Liang, 2010]. SDF-1α 
can recruit angiogenesis promoting myeloid cells, such as granulocytes into tumors and 
stimulate tumor invasiveness; therefore it can promote hematopoietic cell trafficking and 
tumor inflammation. Schmid et al. showed that SDF-1α was highly expressed in the 
microenvironments of PDAC and was involved in the recruitment of pro-angiogenic 
macrophages to tissue. In addition to its chemotactic functions, SDF-1α has also been 
shown to regulate tumor cell proliferation, motility, metastasis, and survival through its 
binding and subsequent activation of CXCR4 (a chemokine receptor specific for SDF-
1α) [Marchesi, 2004]. SDF-1α regulates angiogenesis by recruiting endothelial 
progenitor cells from the bone morrow through a CXCR4-dependent mechanism and 
carcinogenesis and the neovascularization linked to tumor progression. Li et al. showed 
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that there is a cross-talk between SDF-1/CXCR4 axis and non-canonical Hedgehog (Hh) 
pathway in PDAC. The Hh pathway, which is known to control cell proliferation and 
differentiation in developing embryos, is overexpressed in many extracutaneous cancers, 
including PDAC. The activation of the Hh pathway in PDAC could induce an epithelial–
mesenchymal transition (EMT), through upregulating and down-regulating the 
expression of important ECM proteins which results in invasion and metastasis. Elevated 
levels of SDF-1 in patients with PDAC have been linked to a poor outcome [Li, 2012]. 
Platelet-derived growth factor (PDGF-BB) structurally related to VEGF, has the 
physiological role to control connective tissue growth. In cancer, PDGF-BB and its 
receptors stimulate microvascular sprouting by attracting pericytes and smooth muscle 
cells during angiogenesis [Bos, 2005]. Pericytes are branched cells embedded within the 
basement membrane of capillaries and post-capillary venules. They provide an 
incomplete investment to endothelial cells. Thus reinforcing vascular structure and 
regulating microvascular blood flow [Ribatti, 2011]. McCarty et al. hypothesized that the 
overexpression of PDGF-BB in pancreatic cancer would result in an inhibited tumor 
growth but in an increased pericyte coverage of endothelial cells in vivo, rendering the 
tumor vasculature more resistant to antiangiogenic therapy [McCarty, 2007]. 
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I. AIM OF THE WORK 
The present PhD thesis is part of a long-standing research activity regarding the design, 
synthesis, characterization and processing of polymeric materials for biomedical 
applications, carried out by the research group composed of biologists, chemists, 
pharmaceutical technologists and engineers at the Laboratory of Polymeric Materials for 
Biomedical and Environmental Applications (BIOLab) of the Department of Chemistry 
and Industrial Chemistry - University of Pisa. 
This study was funded and developed within the framework of REGIONE LOMBARDIA 
funded project (2009) “Poli(glutammato): bioproduzione di un polimero ecocompatibile 
e sua derivatizzazione in materiali per il packaging attivo di alimenti (GAMMA-PGA)”. 
Pancreatic ductal adenocarcinoma (PDAC) or pancreatic cancer is one of the major 
causes of cancer-related deaths in Western countries. At present, only pancreatic 
resection can improve survival significantly; however, due to late presentation and 
aggressive tumor behavior only a minority (5–10%) of patients can undergo potentially 
curative surgery. To this date, the molecular basis of this aggressive behavior remains 
greatly unclear. Histopathologic analysis shows that pancreatic cancer is surrounded by 
an intense desmoplastic stroma, that can account for a large proportion of the tumor mass. 
This surrounding tumor microenvironment, or stroma, is composed of extracellular 
matrix (ECM), and several cell types. It is now well appreciated that pancreatic cancer 
microenvironment is not a bystander, but actively participates in cancer progression and 
aggressiveness. In this respect, the recent literature demonstrates how tissue engineering 
platform can enhance in vitro models of tumorigenesis and thus hold great promise to 
contribute to future cancer research. The development of three-dimensional (3D) systems 
able to overcome the difficulties and limitations related to two-dimensional (2D) 
pancreatic cancer cell cultures may be valuable. Recently, 3D cultures within a polymeric 
matrix (scaffold) are proposed as a model to study biological processes compared to cells 
grown in 2D. Cancer cells grown into a tissue-like structure in a polymeric matrix may 
closely mimic the biology of tumor development in vivo, and hence can provide a better 
model system for preclinical evaluation of the cytotoxic effect of anticancer agents. 
The present research activity is aimed at the development of 3D culture of pancreatic 
cancer cells in microstructured polymer matrices in order to gain insights in the 
regulation of pancreatic cancer cell proliferation as well as in the view of developing an 
in vitro model for the evaluation of novel anticancer drugs. 
In this context, the evaluation, improvement and processing of biocompatible polymers as 
well as the characterization of produced polymeric scaffolds, are key factors for the 
development of a rational approach to the design of scaffolds for cancer research. 
Furthermore, the technological improvement of the various stages involved in the 
manufacturing of a 3D construct, including materials processing and scaffold cell 
culturing, can allow the optimization and shortening of the process. 
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It is known that even minor variations in the internal geometry and mechanical properties 
of 3D hydrogels can impact cell behavior in terms of survival, growth, and cell fate 
choice. In this sense, the development of polyelectrolyte complexes hydrogels by mean of 
two different techniques represents an important topic of the planned research activity. 
For such purpose, one of the main objective is represented by the design and set up of 
microstructured polyelectrolyte complexes (mPECs) hydrogels based on polymers of 
natural origin, namely chitosan and poly(γ-glutamic acid), and produced employing the 
computer-controlled wet-spinning technique. Computer-controlled wet-spinning 
technique offers the possibility to produce 3D structures with controlled and predefined 
internal microarchitecture and external shape. The processing conditions for the 
obtainment of 3D mPECs, will be optimized through their correlation to the morphology 
of the produced fibers. In the perspective of a long-term in vitro cell culture, a full 
physical-chemical characterization of the hydrogels represents an objective of this PhD 
thesis. A study of their morphology, swelling behavior, chemical structure will be 
investigated as well as mechanical properties and thermal behavior. A further aspect that 
will be addressed concerns a preliminary biological investigation in order to evaluate 
hydrogels biocompatibility and their ability to sustain and promote cell adhesion and cell 
growth. 
Finally a selection of the most promising polyelectrolyte complexes, on the basis of their 
physical-chemical, mechanical and morphological features, will be investigated for their 
ability to support and preserve pancreatic cancer phenotype in order to develop a 3D 
model of the tumor in vitro. For such purpose, attention will be dedicated to the study of 
peculiar cancer features as loss of cell polarity, duct-like structures differentiation and 
multicellular spheroids formation. Moreover, it is well known that tumor cells 
transformation is associated with phenotypic alterations, including protein 
overexpression. In this respect, the overexpression of fascin and some cytokines 
associated with pancreatic cancer invasiveness will be carefully investigated. The 
maintenance of pancreatic cancer phenotype could represent a promising 3D model of the 
tumor in vitro, providing innovative insights on pancreas carcinogenesis processes. 
The research activity will be performed under a multidisciplinary approach and all the 
described objectives will be part of three chapters that constitute the body of this work: 
ü Three-dimensional polyelectrolyte complexes hydrogels based on chitosan and 
poly(γ-glutamic acid): preparation and physical-chemical characterization 
ü Biocompatibility assessment of polyelectrolyte complexes hydrogels 
ü Modeling of pancreatic ductal adenocarcinoma in vitro with three-dimensional 
microstructured polyelectrolyte complexes hydrogels 
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II. LIST OF ABBREVIATIONS 
ANOVA = Analysis of Variance 
ATCC = American Type Culture Collection 
BCA = Bicinchoninic Acid Assay 
BSA = Bovine Serum Albumin 
CLSM = Confocal Laser Scanning Microscopy  
CS = Chitosan 
DAPI = 4′, 6-Diamidino-2-Phenylindole Dihydrochloride 
DMEM = Dulbecco's Modified Eagle Medium 
DPBS = Dulbecco's Phosphate Buffered Saline 
DSC = Differential Scanning Calorimetry 
ECM = Extracellular Matrix 
FDA = Food and Drug Administration 
FITC = Fluorescein Isothiocynate 
FTIR = Fourier Transform Infrared Spectroscopy 
G-CSF = Granulocyte-Colony Stimulating Factor 
IgG = Immunoglobulins  
IL-6 = Interleukin 6 
IL-8 = Interleukin 8 
MIF = Macrophage Migration Inhibitory Factor 
mPECs = Microstructured Polyelectrolyte Complexes 
Mw = Molecular Weight 
PECs = Polyelectrolyte Complexes 
PDAC = Pancreatic Ductal Adenocarcinoma 
PDGF-BB = Platelet-Derived Growth Factor 
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PBS = Phosphate Buffered Saline 
RIPA = Radioimmunoprecipitation Buffer 
SDS-PAGE = Sodium Dodecyl Sulphate Polyacrilamide Gels 
SD = Standard Deviation 
SDF-1α = stromal cell-derived factor 
SEM = Scanning Electron Microscopy 
SW = Swelling Degree 
Tg = Glass Transition 
TGA = Thermogravimetric Analisys 
TPP = Tripolyphosfate 
2D = Two-Dimensional 
3D = Three-Dimensional 
γ-PGA = Poly (γ-glutamic acid)
Chiara Migone PhD Thesis 
	  
III. GLOSSARY 
 
 
Chitosan 
 (CS) 
 
Poly (γ-Glutamic Acid) 
(γ-PGA) 
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Reagents 
 
Resazurin 
 
 
Resorufin
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2 CHAPTER II: Three-Dimensional Polyelectrolyte 
Complexes Hydrogels based on Chitosan and Poly(γ-
Glutamic Acid): Preparation and Physical-Chemical 
Characterization 
2.1 Introduction 
In vivo, cells grow within a complex and bioactive hydrogel scaffold, namely the 
extracellular matrix (ECM) that provides mechanical support while directing cell 
adhesion, proliferation, differentiation, morphology and gene expression. ECM is a 
hydrogel-like structure comprised of several different biopolymers, encompassing a wide 
range of biological, chemical and mechanical properties [Aizawa, 2012]. 
Biologists and bioengineers have investigated many three-dimensional (3D) scaffolds 
that recapitulate aspects of the native cellular microenvironment for in vitro cell culture. 
Among these, hydrogels—crosslinked polymer networks that possess high water 
contents—demonstrate a distinct efficacy as matrices for 3D cell culture. Hydrogels are 
3D cross-linked insoluble, hydrophilic networks of polymers that partially resemble the 
physical characteristics of native ECM. Consequently, they are soft, pliable, wet 
materials with a wide range of potential biomedical applications [Drury, 2003] Recent 
advantages in biomaterial research have enabled engineering of hydrogels to include 
structure and function found in the natural ECM and allow the design and execution of 
systematic studies in cancer biology [Tibbitt, 2009]. In this context, cell-ECM 
interactions are fundamental to carcinogenesis and related signaling events. The 
possibility of re-creating controlled extracellular microenvironments is a key feature of 
hydrogels that can be exploited to study cancer cell-ECM interactions [Loessner, 2010]. 
Hydrogels are kept from dissolution by the presence of radical, chemical, or physical 
crosslinks. The use of non-covalent interactions such as physical crosslinks removes the 
need for radicals or toxic chemical crosslinkers [Hennink, 2002]. Several non-covalent 
modalities have been exploited in the design of hydrogels, including, hydrophobic 
interactions, antigen–antibody interactions, stereocomplex interactions, and ionic 
interactions [Lin, 2005]. One of the major ionic interactions is the formation of 
polyelectrolyte complexes (PECs). In PECs, the interactions between a cationic polymer 
and an anionic polymer are stronger than other secondary binding interactions like 
hydrogen bonding. This type of ionic complexes avoids the use of organic precursors, 
catalysts, or reactive agents, alleviating the concern about toxicity or reactions with a 
therapeutic payload. Since PECs only consist of cationic and anionic polyelectrolytes, 
their complexation is generally straightforward and reversible [Samoilova, 2010]. The 
structure and properties of PECs hydrogels are similar to those of many biological soft 
tissues. PECs hydrogels are the networked structure of polymer chains crosslinked to 
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each other and surrounded by an aqueous solution. PECs networks have been produced 
between chitosan and DNA, chitosan and anionic polysaccharides such as alginate, 
glucosamineglycans, chondroitin, sulfate, hyaluronic acid, heparin, carboxymethyl 
cellulose, pectin, dextran sulfate, xanthan, proteins such as gelatin, albumin, fibroin, 
keratin, and collagen, synthetic anionic polymers such as (polyacrylic acid) and recently 
also with polyamminoacid such poly (γ-glutamic acid) [Tsao, 2011; Hsieh, 2005; Singh, 
2009]. In this study, polyelectrolyte complexes hydrogels from pairs of oppositely 
charged polymers were developed. Chitosan is a linear copolymer of β-(1–4) linked 2-
acetamido-2-deoxy-β-d-glucopyranose and 2-amino-2-deoxy-β-D-glycopyranose (Figure 
1). It is obtained by deacetylation of its parent polymer chitin, a polysaccharide widely 
distributed in nature (e.g. crustaceans, insects and fungi) [Dash, 2011]. The ease of 
availability, low cost, simple preparation, and excellent biocompatibility of chitosan 
makes it a very attractive substratum for cell culture in vitro. 3D tissue growth models 
can be used not only for evaluating the anticancer activities of new drugs but also for 
providing information about the regulation of both autocrine and paracrine growth 
factors that control cancer cell growth [Xu, 2007]. 
 
Fig.1) Representative chemical structure of chitosan. 
Poly (γ-glutamic acid), (γ-PGA) was first discovered as a major constituent in the 
capsule of Bacillus anthracis. γ-PGA, a biodegradable and non-toxic biomaterial, is 
produced by microbial fermentation. It is an unusual anionic polypeptide made of D- and 
L-glutamic acid units that are connected by amide linkages between the α-amino and γ-
carboxylic groups (Figure 2) [Ho, 2009]. 
 
Fig.2) Representative chemical structure of γ-PGA. 
An attractive property of γ-PGA that makes it suitable for such a wide range of 
applications is its anionic nature and high charge density. These properties allow γ-PGA 
to form polyelectrolyte complexes with polycations, such as chitosan at appropriate 
values of pH (Figure 3). 
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Fig.3) Schematic representation of the ionic interactions formation between chitosan and γ-PGA. 
This research activity was aimed at the development of polyelectrolyte complexes 
hydrogels based on two natural occurring polymers, chitosan and poly(γ-glutamic acid), 
prepared by mean of freeze-drying and computer-controlled wet-spinning technique. The 
fundamental investigations of the prepared hydrogels involved physical-chemical 
characterization as scanning electron microscopy (SEM), swelling degree studies, 
Fourier transform-infrared spectroscopy (FT-IR), mechanical compression properties 
using a uniaxial testing machine, thermogravimetric analysis (TGA) and differential 
scanning calorimetry (DSC). 
2.2 Materials 
Chitosan (CS, Mw 45-110kDa, 92% deacetylation degree) and sodium tripolyphosphate 
(TPP) and Dulbecco's Modified Eagle Medium (DMEM) were purchased from Sigma-
Aldrich (Milan, Italy), poly(γ-glutamic acid) (γ-PGA, 100kDa) was obtained from Natto 
Bioscience (Osaka, Japan). Acetic acid, absolute ethanol and all other solvents used were 
commercially available (Carlo Erba, Milan, Italy). Phosphate Buffer Saline solution 
(PBS 10X) was prepared by dissolving 2.0 g of KCl, 2.0 g of KH2PO4•H2O, 80 g of 
NaCl, and 15.6 g of Na2HPO4•12H2O in 1 liter of distilled water. The pH was adjusted to 
7.4 with 10 N NaOH. PBS 10X was used diluted ten folds with sterile distilled water 
(PBS 1X). All solvents used were commercially available (Carlo Erba, Milan, Italy). 
2.3 Methods 
2.3.1 Three-dimensional hydrogels preparation 
2.3.1.1 Preparation of chitosan and chitosan/poly(γ-glutamic acid) polymeric solutions 
Two different kinds of polymeric solution were prepared: 
1) CS solution was prepared by dissolving CS powder (4% w/v) in acetic acid aqueous 
solution (0.2M) with constant overnight stirring; 
2) CS/γ-PGA solutions with different weight ratios of the two components (CS/γ-PGA= 
80:20, 70:30) were prepared by dissolving γ-PGA in dH2O under stirring. CS powder 
was added and then after 1 hour, acetic acid (1%v/v) was added to the aqueous solution 
to dissolve chitosan powder by protoning the amino groups. The solution was left 
overnight under constant stirring in order to obtain a homogeneous solution (pH value 
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around 5). The total concentration of CS and γ-PGA in the prepared solution was 5% 
(w/v). 
2.3.1.2 Preparation of polyelectrolyte complexes hydrogels (PECs) based on chitosan 
and chitosan/poly(γ-glutamic acid) 
The polymer solutions (2 ml) were poured into a 12-tissue culture plate and frozen at -
20°C for 24 hours. Samples were then lyophilized for 72 hours (-50°C, 0.04Torr). The 
PECs hydrogels were categorized into three groups according to weight ratio of the two 
components (Table 1). 
Tab.1) Composition and abbreviation for PECs hydrogels. 
 NOMENCLATURE 
COMPOSITION CS 100 PEC CS/γ-PGA 80:20 PEC CS/γ-PGA 70:30 
Chitosan (g) 0,4 0,4 0,35 
γ-PGA (g) 0 0,1 0,15 
2.3.1.3 Preparation of microstructured polyelectrolyte complexes (mPECs) based on 
chitosan and chitosan/poly(γ-glutamic acid) 
2 ml of polymer solutions were loaded into a syringe equipped with a pump (NE-100, 
New Pump Systems) and forced through a computer-controlled translating spinneret 
(Gauge 22) into an ethanol coagulation bath. The mPECs hydrogels were fabricated 
layer by layer by employing a 0-90° lay-down pattern (Figure 4). Samples were left in 
the coagulation bath for 24 hours and treated with different procedures: 
a) microstructured CS hydrogels were extensively washed with a TPP crosslinker 
solution (4%w/v) and left in TPP overnight; 
b) microstructured CS/γ-PGA PECs hydrogels were rinsed with phosphate buffered 
saline (PBS 1X)/absolute ethanol solutions with different ratios (10/90, 30/70, 50/50, 
90/10 and 100/0) and then left in PBS overnight; 
c) microstructured CS/γ-PGA PECs hydrogels were extensively washed with a TPP 
crosslinker solution (4%w/v) and left in TPP overnight 
Finally the hydrogels were rinsed in dH2O, frozen at -20°C and lyophilized in a freeze-
dryer for 72 h. The mPECs hydrogels were categorized into three groups according to 
weight ratio of the two components and crosslinking treatments (Table 2). 
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Fig.4) Particular of computer-controlled assisted wet-spinning. 
Tab.2) Compositions and crosslinking treatments of mPECs hydrogels. 
 NOMENCLATURE 
COMPOSITION mCS 100 TPP mPEC CS/γ-PGA 80:20 TPP mPEC CS/γ-PGA 80:20 PBS 
Chitosan (g) 0,4 0,4 0,4 
γ-PGA (g) 0 0,1 0,1 
TREATMENT mCS 100 TPP mPEC CS/γ-PGA 80:20 TPP mPEC CS/γ-PGA 80:20 PBS 
TPP washes 1 per hour (4h) 1 per hour (4h)  
PBS/EtOH 
washes (different 
ratios) 
  1 per mixture  
2.3.2 Three-dimensional hydrogels physical-chemical characterization 
2.3.2.1 Morphological analysis by scanning electron microscopy (SEM) 
To investigate the scaffold microstructure, cross-section and surfaces of the samples 
were analyzed by scanning electron microscopy (SEM, model JEOL JSM 300, Japan). 
The samples were first coated with an ultra thin layer of gold-palladium in an ion sputter 
and then examined by SEM. 
2.3.2.2 Determination of swelling degree 
Swelling study of the all the prepared samples was carried out in PBS 1X and in DMEM 
at 37°C for 20 days. At different time intervals the samples were weighted after wiping 
out the surface swelling media with a filter paper. The equilibrium swelling ratio was 
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calculated by the following equation: Equilibrium swelling ratio (%) = (Ws-Wd)/Wd 
where Wd is the weight of the dry sample and Ws is the weight of the swollen sample. 
2.3.2.3 Fourier transform infrared (FT-IR) spectroscopy measurement 
FT-IR spectroscopy was used to examine the peak variation of the amine and carboxylic 
acid groups of the PECs and mPECs hydrogels. Powdered hydrogels were mixed with 
dry KBr and pressed into a transparent disc, with a ratio of 3/100. 
2.3.2.4 Mechanical characterization 
Hydrogels were incubated prior to testing in PBS 1X, pH 7.4. The samples were cut into 
regular disc (diameter: 11 mm; thickness: 4 mm) as indicated by ASTM D 1621-00 
[ASTM, 2010]. A Dynamic Mechanical Thermal Analyzer (DMTA, Rheometric 
Scientific, Inc., NJ, USA) equipped with parallel plates (17 mm diameter) and a chamber 
allowing to perform the test in PBS 1X at 37°C (Figure 5) was used to determine the 
compressive properties of the hydrogels at a constant rate of 1 mm/min up to 80% strain 
[ASTM, 2010]. After testing, the samples were incubated in PBS 1X at 37°C for 2 h and 
then the compressive analysis was repeated. Low-strain and high strain modulus were 
defined as the slope of the two linear regions in the stress-strain curves. Five samples 
were tested for each type of hydrogel. Statistical differences were analyzed using one-
way analysis of variance (ANOVA) [Soper, 2012], and a Tukey test was used for post 
hoc analysis; a p value < 0.05 was considered statistically significant. 
 
Fig.5) Compression test apparatus. 
2.3.2.5 Thermogravimetric analysis (TGA) study 
TGA was carried out with a Thermogravimetric Analyzer TGA Q500 (TA Instruments-
Waters Division, Milan, Italy). All measurements were performed with approximately an 
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equal amount (5 mg) of samples in a nitrogen atmosphere on platinum crucibles. The 
scanning rate was of 10°C/min in the range 0-800°C. 
2.3.2.6 Differential scanning calorimetry (DSC) measurement 
A Mettler DSC-882 (Mettler Toledo, Milan, Italy) differential scanning calorimeter 
equipped with a liquid nitrogen-cooling accessory was used to determine the glass 
transition temperature (Tg) of the prepared hydrogels. The analysis was performed using 
a 5 mg sample in a nitrogen atmosphere on aluminum pans. The scanning rate was 
10°C/min in the range 20-200°C. The following experimental method was adopted: 
heating from 20 to 200°C at 10°C/min, holding at 200°C for 3 min, cooling from 200 to 
20°C at 20°C/min, holding at 20°C for 1 min and finally heating from 20 to 200°C at 
10°C/min. 
2.4 Results and Discussion 
2.4.1 Three-dimensional hydrogel preparation 
Scaffold manufacturing processes should assure a high level of control over macro- and 
micro-structural properties that meet key requirements of specific application. 
Depending on the fabrication process, scaffolds with different architecture can be 
obtained, with random or tailored pore distribution. Several techniques have been 
developed to fabricate scaffolds. In the present study two different techniques to prepare 
polyelectrolyte complexes hydrogels scaffold hydrogels were used, freeze-drying and 
computer-controlled wet-spinning technique. Briefly, freeze-drying involves removal of 
a solvent first by sublimation of a frozen sample and then by desorption of the nonfrozen 
sorbed solvent under reduced pressure. In the freezing stage, the polymer solution is 
cooled down to a temperature where all the material is in a frozen state resulting in the 
formation of ice crystals, forcing the polymer molecules to aggregate into the interstitial 
spaces. Then the solvent is removed by applying a pressure lower than the equilibrium 
vapor pressure of the frozen solvent. The sublimation of the ice crystals causes the 
formations of a highly porous sponge (Figure 6) [O’Brien, 2004]. 
 
Fig.6) Schematic representation of freeze-drying process. 
The freeze-drying fabrication method does not allow an accurate control over scaffold 
external shape and internal morphology. In this sense, computer-assisted wet-spinning 
offers the possibility to produce porous polymeric matrices with reproducible and 
Chapter II: Three-dimensional polyelectrolyte complexes hydrogels based on chitosan and                 
poly(γ-glutamic acid): preparation and physical-chemical characterization 
 
	   65 
customized microstructure and macroshape representing a significant breakthrough in 
scaffolds manufacturing [Puppi, 2012]. The hydrogel fabrication process involves the 
extrusion of a polymeric solution through a X-Y translating needle that is immersed into 
a coagulation bath (Figure 7). 
 
Fig.7a) Scheme of computer-aided wet-spinning apparatus; b) layer-by-layer process. 
A layer composed of parallel fibers is fabricated by depositing the solidifying solution 
filament with a predefined pattern and 3D architectures are built up with a layer-by-layer 
process by fabricating layers with different fiber orientation (0–90°lay-down pattern) one 
on top of the other. By optimizing the processing parameters, mPECs hydrogels were 
developed. mPECs hydrogels were obtained with an X-Y inter-fibre needle translation 
distance (dxy) of 4 mm and 1 mm staggered fiber spacing between successive layers with 
the same fiber orientation. Besides dxy, the most influent processing parameters on fibers 
alignment and morphology were solution flow rate (F), starting needle tip-collection 
plane distance (Z0) and deposition velocity (Vdep) (Table 3). 
Tab.3) Processing conditions of the different kinds of hydrogels. 
 PROCESSING CONDITIONS 
SAMPLE F (mL/h) 
 
Z0 (mm) 
 
Vdep (mm/min) 
 mCS 100 TPP 1,5 4 100 
mPEC CS/γ-PGA 80:20 TPP 6,5 4 600 
mPEC CS/γ-PGA 80:20 PBS 6,5 4 600 
The Additive Manufacturing technique developed during the present activity allows for 
the design and manufacture, by a layer-by-layer approach, of three-dimensional mPECs 
hydrogels with improved control over scaffold microarchitecture and shape. 
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2.4.2 Three-dimensional hydrogels physical-chemical characterization 
2.4.2.1 Morphological analysis of PECs and mPECs hydrogels 
Macroscopically, PECs hydrogels appeared about 7 mm thick (Figure 8a). SEM images 
of PECs hydrogels showed an interconnected pore structure on both the surface (Figure 
8b) and in cross-section (Figure 8c) with a pore size ranging from 50-200 µm (estimated 
by direct measurement using SEM images). Specifically, according to the literature 
[Tsao, 2011a] CS 100, having no complex formation, had the largest pore size compared 
to PECs hydrogels containing γ-PGA presumably due to their degree of ionic complex 
formation. Macroscopic images (Figure 9a) of mPECs hydrogels showed good 
reproducibility of internal architecture and good degree of fibers alignment for the three 
kinds of mPECs hydrogels developed. In their freeze dried state mPECs hydrogels 
partially lost their three-dimensional shape and microstructure, as shown by SEM 
analysis (Figure 9b) even if a porous interconnected morphology was maintained (Figure 
9c). Furthermore, according to the SEM micrographs no significant changes in the 
porous structure were observed. However, mPECs hydrogels recovered the predefined 
geometry and internal architecture upon incubation in aqueous medium. A highly porous 
surface and predefined microstructure would allow in vitro cell adhesion, ingrowth and 
reorganization [Puppi, 2010]. 
 
Fig.8a) Macroscopic appearance of PECs hydrogels b) SEM images of the top surface c) and 
cross-section. 
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Fig 9a) Macroscopic appearance of mPECs hydrogels b) SEM images of the top surface c) and 
cross-section. 
2.4.2.2 Determination of swelling degree 
The swelling equilibrium of all PECs hydrogels is determined by the balance of two 
primary forces: (1) the elastic retractile responses of the networks and (2) the net osmotic 
pressure within the networks resulting from the mobile counterions surrounding the fixed 
charge groups [Kang, 2006]. As previously described, swelling degree studies of all the 
samples were evaluated in physiological conditions through the immersion of the dried 
hydrogels in PBS1X and in DMEM at 37°C for 20 days. All the analyzed samples shared 
similar swelling degree curves displaying the attainment of a maximum value after 1 
hour of immersion followed by a plateau that was roughly maintained for 20 days 
(Figure 10) in all the media. The results of PECs hydrogels indicated that the equilibrium 
swelling degree decreased as the degree of complex formation increased, due to the 
occurring crosslinking effect between chitosan and γ-PGA [Kang, 2006; Lin 2006]. In 
fact, chitosan based hydrogel (CS 100) exhibited a higher value of swelling degree 
(1400-2000%), in comparison to the swelling degree of PECs hydrogels containing γ-
PGA (1100-1200%) (Figure 10a). Similar behavior was observed for mPECs hydrogels 
curve profiles (Figure 10b). As previously described, mPECs hydrogels reached 
equilibrium within 1 h and the addition of γ-PGA in mPECs provided a lower swelling 
degree, in the range of around 500-750%, with respect to the microstructured chitosan 
based hydrogels (mCS100 TPP) which reached a swelling degree of around 1000-
1600%. By comparing the curve profiles of PECs and mPECs the same trend was 
observed, however mPECs hydrogels exhibited overall a lower swelling degree. This 
behavior could be probably due to the thicker internal microstructure of the mPECs 
hydrogels compared to PECs. All the hydrogels preserved their physical integrity upon 
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incubation in PBS1X and in DMEM up to 20 days. This property may enable their 
employment for long-term cell culture applications. 
Fig.10) Swelling kinetic of a) PECs and b) mPECs hydrogels in PBS 1X and in DMEM at 37°C. 
2.4.2.3 FT-IR Spectroscopy 
The formation of ionic complex interactions between chitosan and γ-PGA was confirmed 
through FT-IR spectroscopy analysis. Figure 11 showed FT-IR spectra of chitosan 
powder, γ-PGA powder, PECs and the mPECs hydrogels. On analyzing the spectrum of 
chitosan a characteristic broad bands at 3431 cm-1 was observed corresponding to the 
overlapping of the stretching vibrations of hydroxyl O-H group and amine N-H2 groups. 
C-O stretching vibrations of chitosan appeared at around 1030 cm-1. The absorption 
bands of amide I and amide II were detected at 1651 and 1606 cm-1. The peaks around 
894 and 1155 cm-1 could be assigned to the saccharide structure. The peak observed at 
1424 cm-1 was attributed to CH symmetrical deformation mode. The characteristic peaks 
of γ-PGA appeared at 3400 and 1700 cm-1, corresponding to its N-H bending and 
carboxylic acid group (-COOH) vibrations, respectively [Tsao, 2010]. As shown in 
Figure 11 the FT-IR spectra of the PECs and the mPECs hydrogels suggested the 
formation of the electrostatic complex between the two polymers by the shifting of the 
peak of the (-COOH) of γ-PGA to a lower wavelength (at 1640 nm) and the formation of 
a new peak at 1560 nm likely due to the NH3 bending of the protonated amino group on 
chitosan. 
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Fig. 11) FT-IR spectra of a) PECs and b) mPECs hydrogels. 
2.4.2.4 Mechanical characterization 
During the present research activity, compression characterization in PBS 1X solution 
was carried out on cylindrical samples (diameter: 11 mm; thickness: 4 mm) at a constant 
rate of 1 mm/min in order to investigate the influence of hydrogels structure and 
composition on their mechanical properties. The stress-strain curves of the tested 
samples were characterized by an initial low-strain linear region, followed by an increase 
in the curve slope, and a high-strain linear region with different stiffness (Figure 12). 
 
Fig.12) Representative stress-strain curves of tested hydrogels. 
Low-strain and high strain compressive modulus were defined as the slopes of the two 
linear portions in the stress-strain curve. The low-strain modulus of the tested hydrogels 
was in the range 1,5-20 kPa while the high strain modulus was in the range 25-120 kPa, 
depending on the sample type (Table 4). CS 100 showed a significant lower low-strain 
modulus compared to PECs hydrogels containing γ-PGA (Figure 13). Similarly, mCS 
100 TPP exhibited a significant lower low-strain modulus in comparison to mPECs 
hydrogels. For both kinds of hydrogels (PECs and mPECs) the difference in low-strain 
modulus between hydrogels with different composition (70:30 and 80:20) was not 
statistically significant. In addition, low-strain modulus values of PECs were 
significantly lower compared with mPECs. These results are consistent with those of 
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Soman and coworkers [Soman, 2012], who reported on 3D poly(ethylene glycol) 
diacrylate (PEDGA) microstructured hydrogels produced with a layer by layer printing 
process, suggesting that in the first phase of compression, which is a result of the 
realignment and the reorganization of the struts, the ordered microarchitecture of mPECs 
was critical in affecting the stiffness of the hydrogels. 
Tab.4) Compressive modulus, reported as mean value ± standard deviation, for the different kinds 
of hydrogels developed. 
Sample Low-strain modulus 
(kPa) 
High strain-modulus 
(kPa) 
CS 100 1,7±1,4 26,5±5,2 
PEC CS/γ-PGA 80:20 2,5±1,5 50,8±14,8 
PEC CS/γ-PGA 70:30 2,2±0,6 54,8±16,7 
mCS 100 treated with TPP 9,5±4,6 99,5±1,3 
mPEC CS/γ-PGA 80:20 treated with TPP 11,3±2,9 118,6±9,2 
mPEC CS/γ-PGA 80:20 treated with PBS 16,9±11,8 117,9±9,9 
The high-strain linear response started at a strain level where struts reorganization 
becomes difficult, an effect of the close packing of porous structure [Soman, 2012]. 
According to previous studies, differences of high-strain modulus among hydrogels with 
different composition were statistically significant for both kinds of hydrogels, 
suggesting that the ionic complex interactions between the two polyelectrolyte polymers 
influenced the mechanical properties [Tsao, 2010]. In fact, the chitosan-based hydrogels 
(CS 100 and mCS100 TPP) high strain modulus was significantly lower than that of the 
corresponding γ-PGA-containing hydrogels (PECs and mPECs hydrogels, respectively). 
Confirming what observed for low-strain modulus analysis, high-strain modulus values 
of mPECs were significantly higher than those of PECs (Figure 13). For both kinds of 
hydrogels, no significant differences in high-strain modulus were observed between 
samples with different composition (70:30 and 80:20). Taken together, the results of 
mechanical characterization suggest that the combination of the CS/γ-PGA ionic 
interaction and the defined internal microarchitecture of mPECs hydrogels provided a 
significant improvement in the compressive mechanical properties. 
 
Fig.13) Compressive modulus of PECs and mPECs hydrogels at low and high strain modulus. 
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In order to study the strain and mechanical recovery properties of the developed 
hydrogels after compressive deformation up to 80% strain, the tested samples were 
maintained in PBS 1X for 2 h. After that, their thickness was measured and the 
compressive analysis was repeated. The hydrogels were able to recover up to 85-95% of 
their original thickness (Table 5). No significant differences in thickness recovery were 
observed between PECs sand mPECs hydrogels. 
Tab.5) Thickness recovery percentage of hydrogels. 
Sample Thickness recovery percentage (%) 
CS 100 95,2±4,7 
PEC CS/γ-PGA 80:20 85±4,1 
PEC CS/γ-PGA 70:30 89,1±6,4 
mCS 100 treated with TPP 93,7±9,0 
mPEC CS/γ-PGA 80:20 treated with TPP 87,7±2,9 
mPEC CS/γ-PGA 80:20 treated with PBS 86,8±5,2 
Low and high-strain moduli of PECs and mPECs samples were subjected to a marked 
decrease after the first compressive test (Figures 13 vs Figure 14). The comparative 
conclusions from the first test on differences between hydrogels with different 
composition as well as between mPECs and PECs hydrogels were confirmed. 
 
Fig.14) Compressive modulus of hydrogels at low- and high-strain from the second compression 
test. 
Tumor extracellular environment stiffness has been directly implicated in aiding tumor 
development and progression. Increases in matrix stiffness that enhances cell 
contractility, inflammation and fibrosis have been found to be sufficient to enhance the 
transformation of mammary epithelial cells [Schrader, 2011]. Several studies have 
reported that the mechanical rigidity of a hydrogel plays a significant role in regulating 
the phenotypes of cancer cells adhered to the gel surface [Liang, 2011]. It is known that 
even minor variations in the internal geometry and mechanical properties of 3D 
hydrogels can impact cell behavior including survival, growth, and cell fate choice 
[Aizawa, 2012]. Taken together, all the data resulting from the mechanical tests and from 
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the biological evaluations (where pancreatic cancer cells were seeded on both the 
typologies of hydrogel) [§ Chapter III], suggest that mPECs could represent a promising 
3D model to simulate in vitro the tumor extracellular microenvironment providing an 
important tool for PC biology. 
2.4.2.5 TGA analysis 
The thermal properties of the systems were investigated using thermogravimetric 
analysis. 5 mg of all the samples were analyzed in a nitrogen atmosphere on platinum 
crucibles using a scanning rate of 10°C/min in the range 0-800°C. Figure 15 shows the 
thermogravimetric (TG) curves and the derivative thermogravimetric (DTG) curves of 
the raw materials, PECs and mPECs hydrogels. The DTG curves (Figure 15) of all the 
samples showed a first thermal event in the range 25-140°C, which corresponded to a 
small weight loss of approximately 15% due to the evaporation of absorbed water 
loosely bound to the polymers [de Britto, 2007; Singh, 2009]. DTG curves of raw 
materials exhibited a second thermal event at 303 °C and 350 °C for chitosan and γ-PGA 
respectively, while the physical mixture showed two peaks roughly corresponding to 
those of the pure components (Figure 15a). The stage of weight loss at ≈300° C for the 
chitosan could be attributed to a complex process including dehydration of the 
saccharide rings, depolimerization and decomposition of the acetylated and deacetylated 
units of the polymer [Neto, 2005; de Britto, 2007, Tsao, 2011b]. PECs hydrogels curves 
displayed a second degradation stage that started at lower temperature in comparison 
with those of raw polymers and physical mixture (Figure 15b). This could indicate that 
acetic acid dissolution and freeze-drying procedure could cause structure modifications 
and hence could influence their thermal behavior [Ozgur, 2008]. Moreover, the results 
demonstrated that PECs hydrogels containing γ-PGA were subjected to a loss of thermal 
stability compared to chitosan based hydrogels, suggesting that the introduction of 
glutamic acid group into polysaccharide structure could disrupt the crystalline structure 
of chitosan, especially through the loss of the hydrogen bonding [Singh, 2009]. mPECs 
hydrogels traces (Figure 15c) revealed that the second thermal event was shifted to 
higher temperature compared to the ones of raw materials and to PECs hydrogels, 
suggesting an improvement in their thermal stability. It is possible to speculate that the 
ordered microarchitecture and the extrusion of the mPECs into an ethanol coagulation 
bath could improve their thermal stability. In fact, according to the literature [Hsieh, 
2007], chitosan is not soluble in ethanol. Therefore, rinsing with an ethanol solution 
could promote the deposition of chitosan and thus stabilize the structure. Hsieh et al. 
proposed that the immersion of a chitosan scaffold in ethanol solution might cause 
further deposition of the chitosan without changing the “primary” structure of scaffolds. 
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Fig.15) TG and DTG curves of a) raw polymers and physical mixtures, b) PECs hydrogels and c) 
mPECs hydrogels. 
2.4.2.6 DSC measurement 
DSC analysis was performed on the dried PECs and mPECs samples in order to estimate 
the compatibility between the relevant constituting components. The measurement of the 
glass transition temperature (Tg) of the samples compared to those of the singular 
components was taken as a valid indication of the occurring of intermolecular 
interactions within the complexes. The analyzed temperatures ranged from 20°C to 
200°C in order to prevent the thermal degradation of the samples. The Tg values were 
taken at the inflection points in the second cycle thermograms. Although DSC analysis 
has been generally assumed not to be sensitive enough to detect the relaxation 
temperature of chitosan and chitosan-based products [Dong, 2004], all thermograms of 
the raw polymers, CS/γ-PGA blends, PECs and mPECs hydrogels, showed the presence 
of a glass transition temperature (Tg) (Figure 16). Tg values recorded for PECs and 
mPECs hydrogels did not display remarkable differences thus evidencing the absence of 
effects of microstructuring on the extent of interactions between the polymeric 
components in the complexes (Table 6). Chitosan-based hydrogels (CS 100 and mCS100 
TPP) showed similar Tg values, higher than those of the hydrogels containing γ-PGA. 
PECs and mPECs displayed Tg values comprised between those of pure components, 
thus suggesting a good miscibility between chitosan and γ-PGA. 
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Fig.16) DSC curves of a) raw polymers and CS/γ-PGA blends, b) PECs and c) mPECs hydrogels. 
 
Tab.6) Glass Transition Temperature (Tg) of PECs and mPECs hydrogels. 
Sample Glass Transition Temperature 
(Tg) (°C) 
Chitosan powder 117,6 
γ-PGA powder 106.4 
Chitosan/γ-PGA blends 111 
CS 100 122.6 
PEC CS/γ-PGA 80 20 116.3 
PEC CS/γ-PGA 70 30 111.5 
mCS 100 treated with TPP 122,2 
mPEC CS/γ-PGA 80:20 treated  with TPP 111.7 
mPEC CS/γ-PGA 80:20 treated with PBS 108.4 
 
2.5 Conclusions 
The main result attained during the present activity was the design and optimization of 
the parameters for the development of microstructured PECs hydrogels as three-
dimensional systems for the in vitro study of cancer cell. In particular, it was shown that 
it is possible to manufacture 3D structures with controlled and reproducible internal 
microarchitecture and external shape by collecting with a predefined pattern a solidifying 
filament of CS and CS/γ-PGA solution into a coagulation bath. The developed hydrogels 
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showed an interconnected porous structure for both kinds of hydrogels. The swelling 
behavior results showed that all the samples swelled rapidly, reaching equilibrium within 
1 h and that the hydrogels preserved their physical integrity upon incubation in aqueous 
medium up to 20 days. FT-IR suggested the formation of the electrostatic complex 
between chitosan and γ-PGA. Mechanical properties studies displayed the compressive 
modulus of the hydrogels was deeply affected by the addition of γ-PGA and the 
predefined microarchitecture. TGA and DSC analysis revealed good thermal stability of 
mPECs hydrogels and good miscibility of the two components in both kinds of 
hydrogels. Taken together, these results suggest the suitability of the prepared hydrogels 
as 3D reproducible scaffolds for in vitro cancer cell studies. 
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3 CHAPTER III: Biocompatibility Assessment of 
Polyelectrolyte Complexes Hydrogels 
3.1 Introduction 
Cells grown in vitro in three dimensions (3D) on a polymeric scaffold have been 
extensively investigated in tissue engineering applications. Recently, 3D cultures are 
suggested as a better model to study the complex biological processes than cells grown 
in monolayers [Hutmacher, 2009a]. In cancer research, cancer cells grown into a tissue-
like structure using a scaffold may closely mimic the biology of tumor development in 
vivo. 3D tumor model that accurately recreates the in vivo tumor phenotype would be a 
valuable tool for studying tumor biology and would allow better preclinical evaluation of 
anticancer drug candidates than cells grown in monolayers [Nyga, 2011]. Growth of cells 
in 3D typically involves cell seeding onto a scaffold which, following their adhesion, 
spreading, proliferation, and differentiation, can develop into a tissue-like structure 
[Burdett, 2010; Sahoo, 2005]. One of the essential requirements for promoting 3D 
growth of cells in vitro is to design a suitable polymeric scaffold that provides a 
structural template for cell adhesion and growth. Nevertheless, prior to study phenotypic 
cancer features of cancer cells-seeded scaffolds and evaluate the cytotoxic effect of 
anticancer agents it is necessary to submitt the developed constructs to preliminary 
biological evaluations for the assessment of their biocompatibility. The evaluation of 
biomedical polymers biocompatibility represents a fundamental step in establishing and 
ensuring product applicability and safety. The biological evaluation of medical devices, 
in terms of procedures identifying and quantifying the biological risks associated with 
biomedical materials, is governed by International Organization for Standardization 
(ISO) 10993 in Europe [ISO 10993] and by Food and Drug Administration (FDA) blue 
book memorandum G95-1 in the United States [#95-1, US FDA]. The current 
introduction of ISO 10993 Part 18 states, “the consideration of the chemical 
characterization of the materials from which a medical device is made is a necessary first 
step in assessing the biological safety of the device”. This emphasizes the need by 
biomaterial designers and producers to assess the biological risk of new materials more 
thoroughly. Polymeric biomaterials have been used extensively in different areas of 
medical applications, such as implantable devices, artificial organs, prostheses, dentistry, 
bone repair, drug delivery systems, regenerative tissue engineering [Wang, 2004] and 
more recently in cancer research [Hutmacher, 2010]. Polymers biocompatibility remains 
one of the key aspects that must be investigated since it represents the major factor 
limiting their use in the biomedical field. The term biocompatibility has undergone 
continuous remodeling based on feedback and new insights stemming from the 
development of cell and molecular biology techniques. Currently, it is generally accepted 
that biocompatibility refers not only to minimal cytotoxicity but also to the promotion of 
biological processes that is further the intended use of the material application. In vitro 
cell culture represents a powerful tool for the preliminary screening of biomaterials 
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cytotoxicity. Cultures of mammalian cells are mainly employed for cytotoxicity 
evaluation. Cell-based assays can provide essential information on potential effects of 
chemicals on specific cell properties and provide relevant basis for further molecular 
studies. It is generally accepted that cytotoxicity, which can be defined as “in vitro 
evaluation of toxicological risks using cell culture”, deals with the assessment of various 
aspects of cellular function such as cell viability and proliferation, reduced cell adhesion, 
biosynthetic activity and altered cell morphology. Depending on the structural 
characteristics and on the final application, test materials may be evaluated by specific 
methods. In direct contact methods, cells are seeded directly onto the material or 
alternatively a sample of the test material is placed in the center of a near-confluent 
monolayer of a selected cell line. Qualitative evaluation of morphological changes of 
cytotoxic cellular alterations such as cell detachment, rounding off, granules formation, 
shrinking of cell nucleus and cytoplasm fragmentation is generally carried out by 
examination under an inverted microscope of living or fixed and stained cells. Deeper 
insights on cell morphology in response to biomaterials may come from epifluorescence 
and confocal laser microscopy analysis by the fluorescence staining of cell cytoskeleton 
or nuclei. Further investigation on morphology may come also from scanning electron 
microscopy (SEM) [Chiellini, 2006]. Quantitative evaluation of cell viability can be 
achieved with the use of vital dyes as alamarBlue® assay, that is one of the most popular 
quantitative techniques for the evaluation of cell viability based on the measure of cell 
metabolic functions. alamarBlue® cell viability reagent acts as a cell health indicator by 
using the reducing power of living cells to quantitatively measure the proliferation of 
various human and animal cell lines, bacteria, plant, and fungi allowing to establish 
relative cytotoxicity of agents within various chemical classes. When cells are alive they 
maintain a reducing environment within the cytosol of the cell. Resazurin, the active 
ingredient of alamarBlue® reagent, is a non-toxic, cell permeable compound that is blue 
in color and virtually non-fluorescent. Upon entering cells, resazurin is reduced to 
resorufin, a compound that is red in color and highly fluorescent (Figure 1). Viable cells 
continuously convert resazurin to resorufin, increasing the overall fluorescence and color 
of the media surrounding cells [O’ Brien J, 2000]. 
 
Fig.1a) Resazurin and resorufin structures. Nonreduced alamarBlue® corresponds to resazurin 
and reduced alamarBlue® to resorufin; b) absorbance and fluorescence emission spectra of 
resorufin. 
The aim of this PhD project was the development of 3D culture of pancreatic cancer 
cells in microstructured polymer matrices in order to gain insights in the regulation of 
pancreatic cancer cell proliferation as well as in the view of developing an in vitro model 
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for the evaluation of novel anticancer drugs. Pancreatic ductal adenocarcinoma (PDAC) 
is one of the most deadly of all types of cancer. Hence, further research that can enable 
to get insights into the biology and treatment options is urgently needed. In particular, 
the aim of this PhD thesis chapter was to investigate the ability of both typologies of the 
developed hydrogels [§ Chapter II] to sustain and promote cell adhesion and cell growth. 
In this respect, hydrogels were submitted to preliminary in vitro cell culture experiments 
employing Balb/3T3 fibroblasts cells and then with human pancreatic cancer cells 
BxPC-3 in order to evaluate hydrogels cytocompatibility. Balb/3T3 cell line is one of the 
most commonly used to assess scaffolds biocompatibility [Tsao, 2010; Li, 2012; Reeves, 
2010]. Balb/3T3 cells (Figure 2) is one of several cell lines developed by S.A. Aaronson 
and G.T. Todaro [Aaronson, 1968] in 1968 from disaggregated 14 to 17-day-old 
BALB/c Mus musculus mouse embryos. 
 
Fig.2) Balb/3T3 clone A31 fibroblast cells. 
Human pancreatic cancer cells BxPC-3 cells represent a valuable model of primary 
human pancreatic cancer in vitro. BxPC-3 cells (Figure 3) were isolated from needle 
biopsy specimens of a primary adenocarcinoma of the body of the pancreas from a 61-
years old woman [Tan, 1986]. The patient died 6 months later despite radiation and 
chemotherapy. BxPC-3 cells were classified as moderately differentiated cells. The 
grading system was based on the integrity of membrane structures and on the presence of 
mucin granules, cell organelles, nuclear and cellular polymorphism, cell polarity, and 
lumen formation [Sipos, 2003]. 
 
Fig.3) Human pancreatic cancer cells BxPC-3. 
Cytocompatibility of the developed polyelectrolyte complexes (PECs) and 
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microstructured polyelectrolyte complex (mPECs), in terms of cell viability, 
proliferation and morphology was evaluated by alamarBlue® assay, scanning electron 
microscopy (SEM) and confocal laser scanning microscopy (CLSM), respectively. 
3.2 Materials 
Mouse embryo fibroblasts Balb/3T3 clone A31 cell line (CCL-163) and human 
pancreatic cancer cells BxPC-3 (CRL-1687) were purchased from American Type 
Culture Collection (ATCC). Dulbecco’s Modified Eagle Medium (DMEM), Dulbecco’s 
Phosphate Buffer Saline (DPBS), RPMI 1640 medium, calf serum, fetal serum, sodium 
pyruvate, glutaraldehyde, sodium cacodylate, tetramethylsilane, Triton X-100 were 
purchased from Sigma-Aldrich (Milan, Italy). L-glutamine and penicillin/streptomycin 
solution were obtained from Lonza (Portsmouth, Usa). alamarBlue®, Sytox, phallotoxin-
rhodamine and live/dead® cell viability assay were purchased from Invitrogen (Milan, 
Italy). Phosphate Buffer Saline solution (PBS 10X) was prepared by dissolving 2.0 g of 
KCl, 2.0 g of KH2PO4•H2O, 80 g of NaCl, and 15.6 g of Na2HPO4•12H2O in 1 liter of 
distilled water. The pH was adjusted to 7.4 with 10 N NaOH. PBS 10X was used diluted 
ten folds with sterile distilled water (PBS 1X). All solvents used were commercially 
available (Carlo Erba, Milan, Italy). Paraformaldehyde solution (paraformaldehyde 
3.8%) was prepared by dissolving 1.9 g of paraformaldehyde in 50 ml of distilled water 
adding 5 µl of NaOH at 56°C under gentle stirring to obtain clear solution. Then, 5 ml of 
PBS 10X was added. The solution was filtered and stored at 4°C before use. All solvents 
used were commercially available (Carlo Erba, Milan, Italy). 
3.3 Methods 
3.3.1 In vitro evaluation of cytotoxicity using mouse embryo fibroblast cells 
For cytocompatibility assessment, polyelectrolyte complexes (PECs) and 
microstructured polyelectrolyte complex (mPECs) hydrogels based on chitosan (CS) and 
CS/poly(γ-glutamic acid) (γ-PGA) were sterilized under UV light for half an hour on 
each side. The scaffolds, maintained under sterile conditions, were then covered with a 
solution of ethanol (70%) overnight. When the ethanol solution was removed, scaffolds 
were submitted to repeating washing with DPBS containing a penicillin/streptomycin 
solution (1%). Scaffolds were then incubated overnight with complete culture medium 
(DMEM) before cell seeding. Mouse embryo fibroblasts cells Balb/3T3 clone A31 were 
cultured in DMEM supplemented with of L-glutamine [4Mm], penicillin/streptomycin 
solution [100 U/ml:100µg/m] (1%), calf serum (10%) and antimycotic. Confluent 
Balb/3T3 cells were trypsinized (0.25% trypsin-EDTA solution), detached from the flask 
and seeded on the scaffolds at a density of 2x104 cells/well in a total volume of 1ml and 
were cultivated for 14 days at 37°C, 5% CO2. 
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3.3.1.1 Quantitative evaluation of cell viability and proliferation (alamarBlue® assay) 
Quantitative evaluation of cells viability and proliferation was carried out for direct 
contact toxicity assay and also for the cells seeded onto PECs and mPECs hydrogels, by 
using the alamarBlue® reagent. For direct contact toxicity assay scaffolds were placed in 
contact with a subconfluent monolayer of balb/3T3 cells for 48 hours, and then analyzed 
with alamarBlue® reagent as described below. For the assessment of viability and 
proliferation of cells seeded onto the prepared hydrogels, the cells-seeded scaffolds were 
maintained in culture for different incubation times (2, 5, 8 and 12 days), and then 
treated for 24 hours with the alamarBlue® reagent (10% of the volume of the well) at 
37° C, 5% CO2. Cells seeded onto two-dimensional (2D) conditions, 24-well tissue 
culture polystyrene (TCPS) plates and were used as a control. The supernatant from each 
experiment was then collected and re-plated into 96 wells plate. Measurements of 
resorufin dye absorbance were detected at 565 nm, with 595 nm as reference 
wavelength, using a Biorad Microplate Reader (Figure 4). Percentages of cell 
proliferation were normalized on the basis of fibroblast A31 cells cultured on TCPS 
plates. 
 
Fig.4) Schematic representation of alamarBlue® cell viability assay protocol. 
3.3.1.2 Qualitative analysis of cell viability and proliferation (live/dead® assay) 
Qualitative investigation of cell viability was assessed by the live/dead® assay dyeing at 
14 day of culture. Scaffold samples were washed with DPBS to remove extracellular 
esterase activity prior to incubating with calcein-AM (2 mm) and Ethidium Homodimer-
1(EthD-1) (4 mM) in DPBS for 30 min at room temperature following the producer’s 
protocol. The presence of live (green) and non viable/dead (red) cells was immediately 
assessed using a Nikon Eclipse TE2000 inverted microscope equipped with an EZ-C1 
confocal laser (Nikon, Japan). 
3.3.1.3 Evaluation of cell morphology 
Morphological analysis of balb/3T3 clone A31 cell line cultured on PECs and mPECs 
hydrogels, was carried out by scanning electron microscopy (SEM) at day 14 of culture. 
After culture medium removal, each cell-seeded hydrogel was rinsed twice with DPBS, 
and cells were fixed with 2% glutaraldehyde solution in PBS 1X. After 1 hour of 
incubation, mouse embryo fibroblast cells/hydrogels constructs were rinsed again with 
PBS 1X and treated with sodium cacodylate 0.1 M, pH 7.4 for approximately 1 minute. 
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After cell fixation, specimens were dehydrated in ethanol:water solution of varying 
concentration (i.e. 10, 30, 50, 70, 90, and 100% v/v ethanol respectively) for 15 minutes 
at each concentration. Samples were dried in tetramethylsilane to remove any water 
traces. The fixed scaffolds were mounted on a SEM stub, coated with gold at 15 mA for 
20 min, and observed at different magnifications (400X-3000X magnification). 
Morphology of balb/3T3 clone A31 cells grown on all hydrogels typology was 
investigated also by means of confocal laser scanning microscopy (CLSM) at day 14 of 
culture. Cells were fixed with 3.8% paraformaldehyde for 30 minutes; the samples were 
washed with PBS1X and incubated with 2% PBS1X solution of Triton X-100 for 15 min 
to permealize cells. PBS1X solution of Sytox and phallotoxin-rhodamine was added and 
incubated for 1 h. After dye incubation, the samples were washed with PBS 1X. A Nikon 
Eclipse TE2000 inverted microscope equipped with an EZ-C1 confocal laser and 
Differential Interference Contrast (DIC) apparatus was used to analyze the samples. A 
523 nm laser diode (523 nm emission) and an Argon Ion Laser (565 nm emission) were 
used to excite Sytox and rhodamine fluorophores, respectively. The images were 
captured with Nikon EZ-C1 software using identical instrumental settings for each 
sample. The merged images were processed with ACT-2U software (Nikon-Japan). 
3.3.2 In vitro biological investigation using human pancreatic cancer cells 
Human pancreatic cancer cells BxPC-3 were maintained in RPMI-1640 medium 
containing 4 mM of L-glutamine, 1% of sodium pyruvate 1% of penicillin/streptomycin 
solution (10,000 U/ml:10 mg/ml) 10% of fetal serum and antimycotic. Cells were grown 
in a humidified incubator at 37 °C in a 5% CO2 enriched atmosphere. For 3D cell 
culture, PECs and mPECs hydrogels were sterilized by exposing to UV light for 30 
minutes on each side. Subsequently, hydrogels were soaked in 70% ethanol/water 
solution for 24 hours, washed extensively with DPBS added with penicillin/streptomycin 
solution (1%) pH 7.4 and conditioned overnight in RPMI-1640. BxPC-3 cells (5*104 
cells/well in a total volume of 1 ml) were seeded onto PECs and mPECs hydrogels and 
maintained in culture for 28 days at 37°C, 5% CO2. 
3.3.2.1 Quantitative evaluation of cell viability and proliferation (alamarBlue® assay) 
Quantitative evaluation of cell viability and proliferation was evaluated by alamarBlue® 
reagent as described in § 3.3.1.1. Cells seeded onto 24-well plates TCPS were used as a 
control. Percentages of cell proliferation were normalized on the basis of BxPC-3 cells 
cells cultured on TCPS plates. 
3.3.2.2 Qualitative analysis of cell viability and proliferation (live/dead® assay) 
Qualitative cell viability was assessed by the live/dead® assay dyeing at 28 day of 
culture, as described in § 3.3.1.2. 
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3.3.2.3 Evaluation of cell morphology 
Morphological analysis of BxPC-3 cell line cultured on PECs and mPECs hydrogels was 
carried out by SEM at day 28 of culture. Samples were prepared as described in § 
3.3.1.3, and observed at different magnifications (1000X-5000X magnification). 
Morphology of BxPC-3 cells grown on mPECs hydrogels typology was investigated also 
by means of CLSM at days 28 days as described in § 3.3.1.3. 
3.3.2.4 Statistical analysis 
The in vitro biological tests were performed on triplicates, and the data are represented 
as mean ± standard deviation. Statistical differences were analyzed using one-way 
analysis of variance (ANOVA) [Soper, 2012], and a p value < 0.05 was considered 
significant. 
3.4 Results and Discussion 
3.4.1 In vitro evaluation of cytotoxicity using mouse embryo fibroblast cells 
According to ISO 10993-5 [ISO 10993], established American Type Culture Collection 
cell lines (ATCC), such as fibroblasts NCTC clone L-929 (CCL 1), fibroblasts Balb/3T3 
clone A31 (CCL 163), fibroblasts MRC-5 (CCL 171), fibroblasts WI-38 (CCL 75), and 
epithelial Vero (CCL 81), are preferred for the biological evaluation of medical devices. 
Hence, in the present study, for a preliminary biological investigation of PECs and 
mPECs hydrogels, Balb/3T3 clone A31 mouse embryo fibroblasts were selected. 
3.4.1.1 Quantitative evaluation of cell viability and proliferation (alamarBlue® assay) 
The biocompatibility of all the prepared hydrogels and the influence of the scaffold 
architecture on cell behavior were assessed in a preliminary investigation on cell 
viability, adhesion and proliferation of mouse embryo fibroblasts cells Balb/3T3 clone 
A31, carried out by means of biochemical analysis at days 2, 5, 8 and 12 of culturing. 
Cell viability and proliferation were evaluated by alamarBlue® reagent, both for the 
direct contact toxicity assay and the cells-seeded PECs and mPECs hydrogels. Results of 
direct contact assay at 48 hours for PECs hydrogels showed not significant toxic effects 
on cell viability values for PECs hydrogels (except for PEC CS/γ-PGA 70:30, which was 
around 40%), whereas results of direct contact assay for all the investigated mPECs 
hydrogels displayed no toxicity, with significant higher cell viability values compared to 
PECs hydrogels (p<0,05) (Figure 5) and similar to the control cells grown onto TCPS. 
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Fig.5) Results of direct contact toxicity assay of mouse fibroblasts A31 cells on PECs hydrogels 
and mPECs hydrogels evaluated by alamarBlue assay. 
Quantitative evaluation of cell proliferation on PECs hydrogels measured at each 
endpoint highlighted the presence of viable cells on each typology of constructs, starting 
from day 2 (Figure 6a). Moreover, from day 2 up to day 12 of culture, fibroblasts cells 
cultured on mPECs hydrogels expressed significantly higher values of cell proliferation 
when compared to the ones observed for cells grown onto PECs hydrogels samples 
(p<0,05) (Figure 6b). In fact, it is probable that the microstructured geometry present in 
wet-spun mPECs samples could allow for a more efficient cells seeding procedure, thus 
improving cell colonization of the hydrogels [Li, 2000; Jiankang, 2007]. 
 
Fig.6a) Fibroblasts cells Balb/3T3 clone A31 cell proliferation on PECs and mPECs hydrogels, b) 
an overview on ANOVA statistical analysis at day 2 of culture, this trend was maintained up to 12 
days of culture. 
3.4.1.2 Qualitative analysis of cell viability and proliferation (live/dead®assay) 
Live/dead method, a two-color fluorescence assay (green stain for live cells and red for 
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dead cells), was carried out for mPECs hydrogels. Viable cells were observed for all the 
three typologies of mPECs. At day 14, the ratio between the two fluorescence dyes was 
consistent with a normal cellular adaptation to the hydrogels where some cells failed to 
attach to the material and eventually died. The CLSM micrographs reported in Figure 7, 
showed good cell viability with a high live/dead ratio. The proliferative trend of the 
culture corroborated the alamarBlue® biochemical assay results. 
Fig.7) CLSM images of Balb/3T3 clone A31 cultured on mPECs hydrogels and treated with 
live/dead staining (10X magnification). 
3.4.1.3 Cell morphology investigation 
The microstructure of a matrix has a prominent influence on cell proliferation, function, 
and migration in tissue engineering [Soman, 2012]. Observation of cell morphology is a 
direct way to characterize the condition of cell attachment and proliferation; hence a 
preliminary biological evaluation of cellular spreading and morphology for all the cell-
cultured hydrogels was carried out by SEM and CLSM techniques. SEM analysis was 
performed at day 14 of culture, both on the top and in the cross-section of all the 
samples. As shown by SEM images, cells grown on PECs hydrogels showed round and 
spherical morphologies and were not uniformly distributed but clustered in colonies 
(Figure 8), in contrast cells on mPECs hydrogels displayed a spread out and a fusiform 
shape (Figure 9). 
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Fig.8) SEM images of Balb/3T3 clone A31 cultured on PECs hydrogels: a) top surface and b) 
cross-section. 
 
Fig.9) SEM images of Balb/3T3 clone A31 cultured on mPECs hydrogels: a) top surface and b) 
cross-section. 
Cells grown onto mPECs hydrogels showed features indicative of cell activation, 
including numerous filopodia and fiber-like processes that allowed the anchorage of the 
cells to the substrate with the formation of a complex multicellular coverage [Zhang, 
2011], confirming the previous analysis of cell viability. These results were also 
supported by the CLSM analysis. Sytox and phallotoxin-rhodamine solution treatment 
were used to stain nucleic acids and cytoskeleton, respectively. Figure 10 displays 
images of Balb/3T3 fibroblasts after 14 days cultured on PECs hydrogels; the Balb/3T3 
cells exhibited round and spherical morphologies. In contrast Balb/3T3 cells on mPECs 
hydrogels displayed a more fusiform shape (Figure 11). Furthermore, micrographs 
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randomly taken throughout the cell cultured mPECs hydrogels showed a high degree of 
homogeneous colonization of the microfibers. 
 
Fig.10) CLSM images of Balb/3T3 clone A31 cultured on PECs hydrogels (10X, 20X and 60X 
magnification). 
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Fig.11) CLSM images of balb/3T3 clone A31 cultured on mPECs hydrogels (10X, 20X and 60X 
magnification). 
3.4.2 In vitro biological investigation using human pancreatic cancer cells 
The dismal prognosis of pancreatic ductal adenocarcinoma (PDAC) is due in part to a 
lack of molecular information regarding disease development. Established cell lines 
remain a useful tool for investigating these molecular events. In vitro experimentation 
involving cancer cell lines is a convenient starting point for discovery and proof-of-
concept studies. In this sense, BxPC-3 cells represent a valuable model of primary 
human pancreatic cancer in vitro. At present very few data on 3D tissue culture models 
of pancreatic cancer are available and report on the use of type I collagen-
glycosaminoglycan scaffolds [Grzesiak, 2007] and of collagen type I or Matrigel 
[Deramaudt, 2006; Gutierrez-Barrera, 2007]. To the best of our knowledge, the use of 
chitosan and γ-PGA PECs hydrogels has never been proposed as model for the 3D tissue 
culture of pancreatic cancer. In this respect, it was decided to submit the developed PECs 
and mPECs hydrogels to preliminary biological investigations using human pancreatic 
cancer cells BxPC-3, in order to evaluate their ability to sustain and maintain pancreatic 
cancer cell adhesion and proliferation. 
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3.4.2.1 Quantitative evaluation of cell viability and proliferation (alamarBlue® assay) 
Cell viability and proliferation were evaluated by alamarBlue® reagent both for the 
direct contact toxicity assay and the cells-seeded PECs and mPECs hydrogels. Results of 
direct contact assay at 48 hours showed that all the investigated constructs could be 
considered non-toxic, exhibiting good values of cell viability compared to the control 
cells grown on TCPS. Moreover, as previously observed in the direct contact assay 
performed with mouse fibroblasts balb/3T3, also BxPC-3 cells seeded onto mPECs 
hydrogels showed significant higher cell viability values compared to BxPC-3 cells 
cultured onto PECs hydrogels (p<0,05) (Figure 12). As shown in Figure 13a, from day 2 
up to day 28 of culture, the developed hydrogels were able to support the proliferation of 
human pancreatic cancer cells BxPC-3 in the two investigated typologies of hydrogels, 
namely PECs and mPECs. Nevertheless, during the culturing period, BxPC-3 cells 
grown onto mPECS hydrogels reached significant higher values of cell proliferation with 
respect to values obtained for cells grown onto PECs hydrogels (p<0,05) (Figure 13b). 
These results suggested that the developed mPECs hydrogels were able to support the 
adhesion and proliferation of human pancreatic cancer cells BxPC3 more efficiently that 
the PECs hydrogels, and were thus selected for further biological investigations (§ 
Chapter IV).  
 
Fig.12) Results of direct contact toxicity assay of BxPC-3 cells on PECs hydrogels and mPECs 
hydrogels evaluated by alamarBlue assay. 
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Fig.13a) Cell proliferation of human pancreatic cancer cells BxPC-3 cultured on PECs and 
mPECs hydrogels evaluated by alamarBlue® assay, b) an overview on ANOVA statistical analysis 
at day 2 of culture; this trend was maintained up to 28 days of culture. 
3.4.2.2 Qualitative analysis of cell viability and proliferation (live/dead®assay) 
Live/dead method, a two-color fluorescence assay (green stain for live cells and red for 
dead cells), was carried out in order to qualitatively evaluate cell viability and 
proliferation on mPECs hydrogels. As shown by the CLSM micrographs (Figure 14), 
viable cells were observed for all the three typologies of mPECs. At day 28, the ratio 
between the two fluorescence dyes was consistent with a normal cellular adaptation to 
the hydrogels. The proliferative trend of the culture corroborated the alamarBlue® 
biochemical assay results. 
 
Fig. 14) Live/dead images of human pancreatic cancer cells BxPC-3 cultured on mPECs 
hydrogels (20X magnification). 
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3.4.2.3 Cell morphology investigation  
SEM analysis performed at 28 days of culture revealed significant differences in terms of 
morphology of cells grown onto PECs and mPECs. BxPC-3 cells grown on PECs 
exhibited a round and spherical morphology, suggesting a poor cell adhesion (Figure 15), 
while cells cultured on mPECs showed a complete multicellular coverage, highlighting 
features indicative of good cell adhesion and spreading (Figure 16). These data were also 
confirmed by CLSM analysis. 
 
Fig.15) SEM images of human pancreatic cancer BxPC-3 cells grown on PECs hydrogels: a) top 
surface and b) cross-section. 
 
Fig.16) SEM images of human pancreatic cancer BxPC-3 cells grown on mPECs hydrogels: a) top 
surface and b) cross-section. 
CLSM investigation of BxPC-3 cells cultured onto mPECs hydrogels showed that cells 
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were able to homogeneously colonize the scaffolds (Figure 17), confirming the previous 
data of cell proliferation and scanning electron microscopy. The obtained results suggest 
that the well-ordered microstructure and the predefined geometry of mPECs hydrogels 
might improve and support cancer cells proliferation, probably due to their internal 
geometry mimicking native tissue architecture exhibited in many natural tissues 
[Isenberg, 2006]. Furthermore, as previously mentioned [§ 2.4.2.4, Chapter II], it is 
known that even minor variations in the internal geometry and mechanical properties of 
3D hydrogels can impact cell behavior including survival, growth, and cell fate choice 
[Aizawa, 2012]. Moreover, the internal microarchitecture, the high-interconnected 
porosity of mPECs hydrogels could allow for a good transportation of nutrients and 
products necessary to create cell culture microenvironment, rather than the random 
internal architecture of PECs hydrogels [Puppi, 2010]. These preliminary results indicate 
that the mPECs hydrogels could be promising candidate to act as model for the 3D tissue 
culture of pancreatic cancer. 
 
Fig.17) CLSM images of BxPC-3 cells cultured on mPECs hydrogels (10X, 20X and 60X 
magnification). 
3.5 Conclusions 
Preliminary biological investigations of PECs and mPECs hydrogels were carried out in 
order to evaluate the ability of the prepared hydrogels to support cell adhesion and 
proliferation. Biocompatibility studies revealed that mPECs hydrogels were non toxic 
Chiara Migone PhD Thesis 
	  
	  
and suited for the adhesion and proliferation of both fibroblasts Balb/3T3 clone A31 and 
human pancreatic cancer BxPC-3 cell lines. In particular, BxPC-3 cells seeded onto 
mPECs expressed cell viability values compared with cells grown onto 2D monolayer up 
to 28 days of culture. In vitro biological evaluations of cell morphology indicated that 
BxPC-3 cells grown onto mPECs hydrogels showed a complete multicellular coverage, 
highlighting features indicative of good cell adhesion and spreading. Taken together, 
these data suggested that the ordered microstructured of mPECs hydrogels could 
improve and support cancer cells proliferation and were selected as a potential candidate 
for further biological investigations [§ Chapter IV]. 
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4 CHAPTER IV: Modeling of Pancreatic Ductal 
Adenocarcinoma in vitro with Three-Dimensional 
Microstructured Polyelectrolyte Complexes Hydrogels 
4.1 Introduction 
Pancreatic ductal adenocarcinoma (PDAC) or pancreatic cancer is one of the major 
causes of cancer-related deaths in Western countries [Krug, 2012]. Despite an enormous 
amount of effort spent in the development of cancer chemotherapies, these are effective 
only in a small proportion of patients [Akada, 2005]. At present, only pancreatic 
resection can improve survival significantly; however, due to late presentation and 
aggressive tumor behavior only a minority (5–10%) of patients can undergo potentially 
curative surgery. As reported by the literature, PDAC is characterized by an unusual 
aggressiveness and early occurrence of metastatic disease. To this date, the molecular 
basis of this aggressive behavior remains greatly unclear [Chifenti, 2009]. Hence, more 
research into the biology and treatment options for pancreatic cancer is needed urgently 
[Froeling, 2010]. Histopathologic analysis shows that PDAC is surrounded by an intense 
desmoplastic stroma, that can account for a large proportion of the tumor mass. This 
surrounding tumor microenvironment, or stroma, is composed of extracellular matrix 
(ECM), and several cell types, including an heterogeneous population of fibroblasts, 
pancreatic stellate cells, smooth muscle cells, immune and inflammatory cells, lipocytes 
and endothelial cells [Chu, 2007]. It is now well appreciated that pancreatic cancer 
microenvironment is not a bystander but actively participates in cancer progression and 
aggressiveness. The significance of tumor microenvironment, which can be described as 
the “soil” of cancer cells, has been emphasized, especially the cancer-stroma interaction, 
which has become critical determinants of cancer behavior [Chen, 2012]. In this respect, 
the recent literature [Hutmacher, 2010] demonstrates how tissue engineering platform 
can enhance in vitro models of tumorigenesis and thus hold great promise to contribute 
to future cancer research. The development of three-dimensional (3D) systems able to 
overcome the difficulties and limitations related to two-dimensional (2D) pancreatic 
cancer cell cultures may be valuable. Recently, 3D cultures within a polymeric matrix 
(scaffold) are proposed as a model to study biological processes compared to cells grown 
in 2D [Geckil, 2010]. Although monolayer cultures recapitulate some of the phenotypic 
traits observed clinically, they are limited in their ability to model the full range of 
microenvironmental cues, such as ones elicited by 3D cell–cell and cell–extracellular 
matrix interactions [Shang-Fong, 2013]. Hence, to successfully investigate the 
pathobiology of human cancer, it is necessary to maintain or recreate the characteristic 
3D architecture of the tissue in culture. Cancer cells grown into a tissue-like structure in 
a polymeric matrix may closely mimic the biology of tumor development in vivo and 
hence can provide a better model system for preclinical evaluation of the cytotoxic effect 
of anticancer agents [Kim, 2005]. At present data on 3D tissue culture models of 
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pancreatic cancer are very limited; only few studies report on the use of type I collagen-
glycosaminoglycan scaffolds [Grzesiak, 2007] and of collagen type I or Matrigel 
[Deramaudt, 2006; Gutierrez-Barrera, 2007]. Hence, the growth of pancreatic cancer 
cells in a 3D hydrogel substrate, able to overcome the drawbacks related to the 
traditional pancreatic cancer cells cultured in vitro [Feder-Mengus, 2008] could provide 
insights on pancreas carcinogenesis and on new therapeutic target for inhibition of tumor 
progression. In this respect, it is well known that tumor cells transformation is associated 
with phenotypic alterations, including protein overexpression [Yosuke, 2005]. In 
particular, the overexpression of fascin and some cytokines, are associated with PDAC 
invasiveness [Xu, 2011; Schmid, 2011; Feurino, 2007]. Fascin protein overexpression 
was identified as a biomarker typical for pancreatic cancer cells [Xu, 2011]. Fascin, a 
globular actin-crosslinking protein, is associated to the development of cancer phenotype 
and invasiveness in pancreatic cancer [Maitra, 2003]. The rearrangement of the actin 
cytoskeleton induced by fascin overexpression in pancreatic cancer cells promotes their 
motility, migration and invasion, leading to a more aggressive phenotype [Yosuke, 
2005]. Recent data from a number of laboratories have highlighted that fascin is up-
regulated in many human carcinomas and, in individual tissues, correlates with the 
clinical aggressiveness of tumors and poor patient survival [Yamaguchi, 2007]. 
Cytokines are a vast and diverse group of glycosylated peptides produced by virtually all 
nucleated cells in human body, playing important roles in regulating cell growth and 
inflammation. Although the functional link between inflammation and pancreatic cancer 
has not been elucidated, several studies have shown the involvement of inflammatory or 
proinflammatory cytokines in cancer development and aggressiveness [Joshita, 2009; 
Feurino, 2007; Schmid, 2011]. From the recent literature, it is known that the 
overexpression of cytokines is correlated to cancer aggressiveness, metastatic potential 
and modulation of tumor-associated neoangiogenesis [Waugh, 2008; Liang, 2010]. 
Tumor growth and spread of tumor cells requires angiogenesis [Hendriksen, 2009], in 
this sense malignant tumor cells recruit or activate the local vasculature and stroma 
through production and secretion of stimulatory growth factors and cytokines 
[Birgersdotter, 2005]. Research into these mechanistic studies has led to a growing area 
of interest in the role of cytokines in PDAC progression, in particular the creation of a 
favorable tumorigenic conditions and aggressively resistant metastasis [Feurino, 2006]. 
The capability to identify sensitive and effective biomarker proteins is critical in the 
battle against cancer, because the ability to treat and cure cancer, particularly pancreatic 
cancer, directly depends on the ability to detect it at its earliest stage [Chen, 2005].  
In this PhD research activity two different typologies of hydrogels were prepared: 
polyectrolyte complexes (PECs) and microstructured polyelectrolyte (mPECs) hydrogels 
based on chitosan and poly(γ-glutamic acid) (γ-PGA). Taking into account the results of 
the physical-chemical, mechanical and preliminary biological characterizations described 
in Chapter II and Chapter III, mPECs were selected as a potential candidate to be 
submitted to a comprehensive biological investigation with human pancreatic cancer 
cells BxPC-3. Hence, the main aim of the present chapter is to evaluate the ability of 
developed mPECs to support and maintain PDAC phenotype. In this study, PDAC 
features of BxPC-3 cells grown onto mPECS were investigated; fascin protein was 
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selected as marker of tumor invasiveness and its overexpression was investigated by 
CLSM and fluorescent western blotting technique. Moreover, the expression of several 
cytokines, associated with PDAC aggressiveness, was also investigated by luminex 
technology. 
4.2 Materials 
Phosphate Buffer Saline solution (PBS 10X) was prepared by dissolving 2.0 g of KCl, 
2.0 g of KH2PO4•H2O, 80 g of NaCl, and 15.6 g of Na2HPO4•12H2O in 1 liter of 
distilled water. The pH was adjusted to 7.4 with 10 N NaOH. PBS 10X was used diluted 
ten folds with sterile distilled water (PBS 1X). All solvents used were commercially 
available (Carlo Erba, Milan, Italy). Paraformaldehyde solution (paraformaldehyde 
3.8%) was prepared by dissolving 1.9 g of paraformaldehyde in 45 ml of distilled water 
adding 5 µl of NaOH at 56°C under gentle stirring to obtain clear solution. Then 5 ml of 
PBS 10X was added. The solution was filtered and stored at 4°C before use. All solvents 
used were commercially available (Carlo Erba, Milan, Italy). Tween 20 were purchased 
from Carlo Erba (Milan, Italy); human pancreatic cancer cells BxPC-3 (CRL-1687) were 
purchased from American Type Culture Collection (ATCC). RPMI 1640 medium, 
Dulbecco’s Phosphate Buffer Saline (DPBS), calf serum, fetal serum, sodium pyruvate, 
glutaraldehyde, sodium cacodylate, tetramethylsilane, Triton X-100, bovine serum 
albumin (BSA), phalloidin-tetramethylrhodamine B isothiocyanate, 
radioimmunoprecipitation (RIPA) buffer, protease inhibitors, phosphatase inhibitors 
were purchased from Sigma-Aldrich (Milan, Italy); bicinchoninic acid assay (BCA) 
protein assay kit was purchased from Pierce (Rockford, IL, USA); primary antibody anti-
human fascin clone 55K-2 and secondary antibody anti-mouse Immunoglobulins-
fluorescein isothiocynate (IgG-FITC) conjugated were purchased from Dako (Glostrup, 
Denmark); 4’-6-diamidino-2-phenylindole (0,02% v/v) (DAPI) was purchased from 
Invitrogen (Milan, Italy); Immun-Blot Low Fluorescence PVDF Membrane, sodium 
dodecyl sulphate polyacrilamide gels, multiple cytokine assay Bio-Plex systems and the 
cytokine reagent kit were purchased from Bio-Rad (Milan, Italy). 
4.3 Methods 
4.3.1 Culture of human pancreatic cancer cell line BxPC-3 onto microstructured 
polyelectrolyte complexes (mPECs) hydrogels 
Human pancreatic cancer cells BxPC-3 were maintained in RPMI-1640 medium 
containing 4 mM of L-glutamine, 1% of sodium pyruvate, 1% of penicillin/streptomycin 
solution (10,000 U/ml:10 mg/ml) 10% of fetal serum and antimycotic. Cells were grown 
in a humidified incubator at 37 °C in a 5% CO2 enriched atmosphere. 
For three-dimensional (3D) cell culture, microstructured polyelectrolyte complexes 
(mPECs) hydrogels based on chitosan (CS) and poly(γ-glutamic acid) (γ-PGA) were cut 
into cut into pieces of 0.25 cm2 and sterilized by exposing to UV light for 30 minutes on 
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each side. Subsequently, hydrogels were soaked in 70% ethanol/water solution for 24 
hours, washed extensively with Dulbecco’s Phosphate Buffer Saline (DPBS), added with 
penicillin/streptomycin solution (1%) pH 7.4 and conditioned overnight in RPMI-1640. 
BxPC-3 cells (5*104 cells/well in a total volume of 1 ml) were seeded onto mPECs 
hydrogels. For two-dimensional (2D) monolayer cell culture, BxPC-3 cells (5*104 
cells/well in a total volume of 1 ml) were seeded onto 24-well plates (tissue culture 
polystyrene, TCPS). 
4.3.1.1 Immunofluorescence staining by confocal laser scanning microscopy (CLSM) 
Cell morphology, (3D) culture organization and fascin detection of BxPC-3/mPECs 
constructs were investigated by means of confocal laser scanning microscopy (CLSM) at 
days 7, 14, 21, 28, 35, 42 after seeding. BxPC-3 cells cultured on mPECs hydrogels were 
fixed with 3.8% paraformaldehyde in PBS 1X for 1 hour, permeabilized in PBS 
1X/Triton X-100 solution (0.2% v/v) for 15 min, and blocked with bovine serum 
albumin (BSA, 1% w/v in PBS 1X) for 30 min. Indirect immunofluorescence was used 
to qualitatively evaluate fascin expression, hence BxPC-3 cells/constructs were 
incubated with the primary antibody anti-human fascin clone 55K-2 (1:50 in BSA) for 2 
hours at 37°C and washed three times with BSA solution (1% w/v in PBS 1X). 
Subsequently, samples were incubated for 2 hours with the secondary antibody anti-
mouse IgG-fluorescein isothiocynate (FITC) conjugated (1:80 in BSA). Samples were 
then incubated with a solution of 4’-6-diamidino-2-phenylindole (0,02% v/v) (DAPI) for 
1 h to visualize cell nuclei (blue) and with phalloidin-tetramethylrhodamine B 
isothiocyanate (0,1% v/v) for 45 min to stain cell cytoskeleton (red). A Nikon Eclipse 
TE2000 inverted microscope equipped with an EZ-C1 confocal laser and Differential 
Interference Contrast (DIC) apparatus was used to analyze the samples (Nikon). A 405, 
laser diode, a solid state laser (561 nm emission) and an Argon Ion Laser (488 nm 
emission) were used to excite respectively DAPI, Rhodamine B fluorophores and FITC. 
Images were captured with Nikon EZ-C1 software with identical instrumental settings 
for each sample. Images were further processed with The GIMP (GNU Free Software 
Foundation) image manipulation software and merged with Nikon ACT-2U software. 
4.3.1.2 Fluorescent western blotting 
Fascin protein expression in BxPC3/mPECs constructs was quantified by mean of 
fluorescent western blotting. Fluorescent western blotting is an analytical technique used 
for the identification and quantification of a specific protein in a biological sample. 
Specifically, a target protein is interrogated by antigen-specific primary antibodies, 
which are then probed by secondary antibodies labeled with a fluorophore to perform 
non-enzymatic detection of protein expression (Figure 1). 
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Fig.1) Schematic representation of fluorescent western blotting 
On days 7, 14, 21, 28, 35, 42 and 49 of culture, BxPC-3/mPECs constructs were 
solubilized in a modified radioimmunoprecipitation (RIPA) buffer (50 mM Tris-HCl, pH 
8.0, with 150 mM sodium chloride, 1.0% Igepal CA-630 “NP-40”, 0.5% sodium 
deoxycholate, and 0.1% sodium dodecyl sulphate) added with protease inhibitors (1:400 
in RIPA buffer) and 1% phosphatase inhibitors for 30 min on ice. The total extract was 
cleaned by centrifugation at 13000 rpm/min for 10 min at 4°C, and the supernatant was 
collected. The protein content in the supernatant was quantified using the bicinchoninic 
acid assay (BCA) protein assay kit and 1.5 µg of total protein was separated on a 10% 
sodium dodecyl sulphate polyacrylamide gels (SDS-PAGE). The proteins were 
electrophoretically transferred onto Immun-Blot Low Fluorescence PVDF Membrane, 
blocked in tris-buffered saline, Tween 20 (TTBS) containing 3% BSA at 4°C overnight, 
and the membrane was incubated with primary antibody anti-human fascin (1:500) for 1 
h at room temperature. After washing, the membrane was incubated with a secondary 
antibody anti-mouse IgG-FITC conjugated (1:3000) for 1h at room temperature. After 
washing, the antigens were revealed by fluorescence detection. Immunoreactive bands 
were captured using a Gel Doc XR (Bio-Rad, Milan, Italy) and band intensity was 
developed in combination with Quantity-One software (Bio-Rad, Milan, Italy). 
Statistical differences were analyzed using one-way analysis of variance (ANOVA) 
[Soper, 2012] and a p value < 0.05 was considered statistically significant. 
4.3.1.3 Mutiplex cytokine assay 
The concentration of the following cytokines: platelet derived growth factor (PDGF-
BB), interleukin 8 (IL-8), interleukin 6 (IL-6), macrophage migration inhibitory factor 
(MIF), stromal cell-derived factor (SDF-1a), granulocyte-colony stimulating factor (G-
CSF), vascular endothelial growth factor (VEGF), was assessed by multiple cytokine 
assay Bio-Plex systems (Bio-Rad Laboratories) and the cytokine reagent kit according to 
the manufacturer’s protocol. The Bio-Plex system is built around three core 
technologies. The first is the family of fluorescently dyed microspheres (beads) to which 
biomolecules are bound. The second is a flow cytometer with two lasers and associated 
optics to measure biochemical reactions that occur on the surface of the microspheres. 
The third is a high-speed digital signal processor that efficiently manages the fluorescent 
output. The Bio-Plex suspension array system employs patented multiplexing technology 
that uses up to 100 color-coded bead sets, each of which can be conjugated with a 
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specific reactant. Each reactant is specific for a different target molecule. Bio-Plex 
cytokine assays are designed in a capture sandwich immunoassay format. Antibody 
specifically directed against the cytokine of interest is covalently coupled to color-
coded 5.6 µm polystyrene beads. The antibody-coupled beads are allowed to react with a 
sample containing an unknown amount of cytokine,  or with a standard solution 
containing a known amount of cytokine.  After performing a series of washes to remove 
unbound protein, a biotinylated detection antibody specific for a different epitope on the 
cytokine is added to the beads. The result is the formation of a sandwich of antibodies 
around the cytokine. The reaction mixture is detected by the addition of streptavidin-
phycoerythrin (streptavidin-PE), which binds to the biotinylated detection antibodies. 
The constituents of each well are drawn up into the flow-based Bio-Plex suspension 
array system, which identifies and quantitates each specific reaction based on bead 
color and fluorescence (Figure 2). 
 
Fig.2) Schematic representation of mutiplex cytokine assay system. 
Briefly, after 21, 28, 35 and 49 days of culture, BxPC-3 cells grown onto TCPS and onto 
mPECs hydrogels were lysed as previously reported (§ 4.4.1.2). Measurements and data 
analysis of all assays were performed using the Bio-Plex System in combination with 
Bio-Plex manager software. Data were normalized to 0.2 mg/ml of total protein 
concentration. 
4.4 Results and Discussion 
4.4.1 Biological characterization of human pancreatic cancer cells BxPC-3 
grown onto mPECs 
In this study, mPECs hydrogels based on chitosan and poly(γ-glutamic acid) (γ-PGA) 
prepared by computer-controlled wet spinning [§ 2.3.1.3] were submitted to a 
comprehensive biological investigation with the moderately differentiated human 
pancreatic cancer cells, BxPC-3 [Sipos, 2003]. A comprehensive biological investigation 
with BxPC-3 cells was carried out in order to evaluate the ability of the prepared 
hydrogels to support cell adhesion, proliferation and the maintenance of the cancerous 
phenotype. 
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4.4.1.1 Investigation of fascin protein expression by CLSM  
Indirect immnufluorescence was performed to evaluate qualitatively by CLSM, the 
expression of fascin protein in BxPC-3 cells grown onto all the three typologies of 
mPECs constructs and onto TCPS. Fascin is an actin-binding protein that functions in 
organizing two different forms of actin-based structures. Fascin expression is often 
absent in normal epithelial cells, such as the epithelia of the bile duct, breast, colon, 
ovary, and pancreas. Fascin expression is upregulated in several human neoplasms, such 
such as breast, lung, kidney, ovary, prostate and pancreatic cancers and it is involved in 
cell interaction, cell migration and cytoarchitecture, which resulted in a more aggressive 
pancreatic cancer phenotype [Xu, 2011]. In the present study, striking differences were 
observed in the expression of fascin protein between 2D and 3D conditions. Qualitative 
images (Figure 3a) showed a very low or absent expression of fascin protein when 
BxPC-3 cells were cultured on monolayers cultures, whereas in 3D conditions, the 
results after 14 days of culture (Figure 3b) displayed that fascin was highly expressed. 
 
Fig.3) CLSM micrographs of BxPC-3 cells grown onto a) TCPS and onto b) mPECs hydrogels 
(60X magnification). Cells were stained with anti-human fascin clone 55K-2/IgG-FITC (green), 
DAPI (blue) and phalloidin-tetramethylrhodamine B isothiocyanate (red). 
Fascin protein was overexpressed in cells grown onto all the typologies of mPECs 
hydrogels up to 40 days of culture (Figure 4). 
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Fig.4) CLSM staining for human fascin antibody (green), phalloidin-tetramethylrhodamine B 
isothiocyanate for actin filaments (red) and DAPI for nuclei (blue) at the indicated time points 
(60X magnification). 
Further investigations exhibited fascin overexpression predominantly localized in 
filopodia cell protrusions (Figure 5a) and in the rim of cell aggregates (Figure 5b), 
suggesting fascin involvement in cell migration and invasiveness [Yamada, 2007]. 
 
Fig.5a) BxPC-3 cells grown onto mCS 100 treated with TPP: fascin accumulation in filopodia cell 
protrusions; b) BxPC-3 cells grown onto mPEC CS/γ-PGA 80:20 treated with TPP: fascin 
expression on the rim of cell aggregates (60X magnification). 
The process of cell migration is poorly understood in epithelial cells, but studies in many 
types of carcinoma cells have documented increased formation of cell protrusions at cell 
margins [Jawary, 2003]. Fascin localizes the core actin bundles of spikes and filopodia at 
the leading edge of migratory cells and that has been implicated in cell motility in 
several cell types [Kureishy, 2002]. BxPC-3 cells cultured in 3D maintained the cancer 
features typical of the cell line as loss of cell polarity and duct-like structures 
differentiation. As shown in figure 6a from day 7 of culture, BxPC-3 cells revealed a loss 
of cell polarity consisting of a disruption of cell apical-basal architecture. This feature is 
oncogene-induced and it is an important hallmark in many epithelial cancers [Feder-
Mengus, 2008], moreover is typically associated with tumor progression in vivo [Sodek, 
2009]. The results after 21 days of culture showed duct-like structures differentiation 
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(Figure 6b), which is one of the main histological characteristics of pancreatic cancer 
[Hezel, 2006]. 
 
Fig.6) BxPC3 cells grown onto: a) mPEC CS/γ-PGA 80:20 treated with PBS: loss of cell polarity 
b) mPEC CS/γ-PGA 80:20 treated with TPP: duct-like structures differentiation (60X 
magnification). 
BxPC-3 cells cultured in 3D were characterized by an additional peculiar cancer feature,  
that was not observed in 2D monolayer cultures: multicellular spheroids development. 
(Figure 7). Multicellular spheroids are small, tightly bound cellular aggregates. These 
cellular aggregates can range in size from 20 µm up to 1 mm in diameter, depending on 
the cell type and growth conditions. Spheroids have been widely used in cancer research 
because the 3D architecture and extensive cell–cell contacts provided by spheroid 
growth appear to better mimic the in vivo cellular environment than 2D monolayer 
cultures. Spheroids also exhibit many of the biological properties of solid tumors, 
including cell morphology, growth kinetics, gene expression, and drug response 
[Burdett, 2010]. Multicellular spheroids development could resemble cancerous tissues 
in terms of structural and functional properties [Lin, 2008]. Homogeneous populations of 
spheroids may prove valuable for high-throughput drug screening [Kunz-Schughart, 
2004], can also be used to study the adhesive properties of tumor cells [Winters, 2005], 
and their behavior can be analyzed by computational modeling [Frieboes, 2006]. 
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Fig.7a, b) BxPC-3 cells spheroids with lumen formation on mPEC CS/γ-PGA 80:20 treated with 
TPP, c) BxPC-3 cells grown on 2D tissue culture polystyrene plates (60X magnification). 
4.4.1.2 Investigation of fascin protein expression by fluorescent western blotting 
Fluorescent Western blotting analysis was performed for the first time to investigate 
semi-quantitatively the expression of fascin protein in human pancreatic cancer cell line 
BxPC-3 cultured both on 2D conditions and on mPECs hydrogels. The use of fluorescent 
detection methods can provide a greater sensitivity than chemiluminescent detection 
methodologies [Brujeni, 2009]. The results obtained from fluorescent western blotting 
analysis showed that BxPC-3 cells grown onto TCPS failed to express fascin protein, 
except at 7 day of culture (Figure 8a-b), indicating that 2D cell culture systems were 
limited in their ability to model the full range of microenviromental cues, such as lack of 
reproduction of physiological patterns of cell adherence, cytoskeletal organization, 
migration and signal transduction [Ingber, 2008]. On the contrary, BxPC-3 cells grown 
onto mPECs hydrogels showed an increasing trend of fascin overexpression up to 40 
days of culture (Figure 8a-b). Specifically, at 21 days of culture BxPC-3 cells seeded 
onto microstructured chitosan-based hydrogels exhibited a peak of fascin overexpression 
significantly higher than mPECs hydrogels containing γ-PGA (p<0,001). For longer 
culture times, (28 and 35 days), BxPC-3 cells cultured onto mPECs hydrogels containing 
γ-PGA showed an increased overexpression of fascin levels than cells cultured on 
microstructured chitosan-based hydrogels (p<0.001) (Figure 8c). Results highlighted that 
mPECs based on chitosan and γ-PGA are able to support and maintain pancreatic cancer 
cell characteristics for over than 35 days of culture, indicating their suitability as 
synthetic matrix for a 3D in vitro model of the tumor. 
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Fig.8a) Western blot for fascin protein of BxPC-3 cells grown onto TCPS, mCS 100 treated with 
TPP, mPEC CS/γ-PGA 80:20 treated with TPP and mPEC CS/γ-PGA 80:20 treated with PBS; b) 
Band intensity (represented by pixels) developed by Quantity One software; c) an overview on 
ANOVA statistical analysis at 21, 28 and 35 days of culture. 
4.4.1.3 Determination of cytokines production by multiplex cytokine assay 
Inflammatory cytokines, chemokines and growth factor are induced under different 
pathologic conditions, including neoplasia. From the recent literature, it is known that 
the overexpression of cytokines is correlated to cancer aggressiveness, metastatic 
potential and modulation of tumor-associated neoangiogenesis [Waugh, 2008; Liang, 
2010]. Although the functional link between inflammation and pancreatic cancer has not 
been elucidated, several studies have shown the involvement of inflammatory or 
proinflammatory cytokines in pancreatic development and aggressiveness [Bharadwaj, 
2007]. Hence, the expression of several cytokines associated with pancreatic cancer 
invasiveness was investigated by luminex technology. As a whole (Figure 9), the results 
obtained by luminex technology showed that for most of the investigated cytokines (G-
CSF, MIF, SDF-1α, IL-8, PDGF-BB), the production was higher when BxPC-3 cells 
were grown on mPECs hydrogels with respect to 2D growth conditions. G-CSF and MIF 
expression, known to promote the proliferation of tumor cells, enhancement of 
metastasis and to influence several important biological mechanisms by which tumors 
thrive and spread [Kobayashi, 2012; Harper, 2010], were present at high levels in cell 
lysate (103-104 pg/ml). SDF-1α, involved in myeloid cell recruitment to tumors and 
subsequent angiogenesis [Li, 2012], was detectable at levels around a 102-103 pg/ml. IL-
8, known for its potent chemotactic activity and considered an important component of 
tumor microenvironment [Chen, 2012], was expressed at levels about 102-10 pg/ml, as 
Chapter IV: Modeling of pancreatic ductal adenocarcinoma in vitro with three-dimensional microstructured 
polyelectrolyte complexes hydrogels	  
	  
well as, PDGF-BB which inhibits tumor growth, but it is involved in an increased 
pericyte coverage of endothelial cells in vivo, rendering the tumor vasculature more 
resistant to antiangiogenic therapy [McCarty, 2007]. Only VEGF and IL-6, involved in 
tumor spread in many type of cancer [Feurino, 2007], had comparable levels with Bx-
PC-3 cells grown in 2D.  
 
Fig.9) Multiplex cytokine assay results of BxPC-3 cells grown onto TCPS, mCS 100 treated with 
TPP, mPEC CS/γ-PGA 80:20 treated with TPP and mPEC CS/γ-PGA 80:20 treated with PBS. 
Taken together, the data resulting from the undertaken biological evaluations confirm the 
importance of tridimensional supports to simulate in vitro the tumor extracellular 
microenvironment providing an important tool for pancreatic cancer biology. 
4.5 Conclusions 
A comprehensive biological investigation of mPECs hydrogels were carried out using 
human pancreatic cancer cells BxPC-3. BxPC-3 cells grown onto mPECs hydrogels 
demonstrated to be able to support and maintain pancreatic cancer phenotype 
differentiating them from 2D monolayer cultures, preserving and increasing the ability of 
the pancreatic cancer cells to overexpress fascin protein and cytokines up to 40 days of 
culture. CLSM displayed that fascin protein was highly present in pancreatic cancer cells 
grown in 3D. Fluorescent western blotting was performed for the first time to detect 
fascin protein expression and confirmed the results obtained from CLSM. Multiplex 
cytokines assay revealed that BxPC-3 cells cultured on mPECs hydrogels expressed high 
levels of cytokines involved in tumor aggressiveness. The obtained results suggest that 
the developed mPECs hydrogels could represent a promising model for the maintenance 
of pancreatic phenotype in vitro, providing innovative insights on pancreas 
carcinogenesis processes. 
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5 CHAPTER V: Overall Conclusive Remarks 
The research activity reported in the present thesis is the result of experimental activities 
performed at the Laboratory of Bioactive Polymeric Materials for Biomedical and 
Environmental Applications of the University of Pisa. The three-year PhD fellowship 
was funded and carried out within the framework of REGIONE LOMBARDIA funded 
project (2009) “Poli(glutammato): bioproduzione di un polimero ecocompatibile e sua 
derivatizzazione in materiali per il packaging attivo di alimenti (GAMMA-PGA)”. The 
present PhD program has been carried out in the emerging interdisciplinary field of 
tissue engineering with the aim of developing three-dimensional (3D) culture of 
pancreatic cancer cells in microstructured polymer matrices in order to gain insight in the 
regulation of pancreatic cancer cell proliferation. In this sense, optimized 
microstructured polyelectrolyte complexes (mPECs) hydrogels were prepared by mean 
of a new technique. mPECs hydrogels demonstrated to be able to support cancer cell 
proliferation and to maintain pancreatic cancer phenotype differentiating them from two-
dimensional (2D) cultures, preserving and increasing the ability of the pancreatic cancer 
cells to overexpress markers specific cancer phenotype such as fascin protein and 
cytokines. These results suggest that mPECs could represent a promising model for the 
maintenance of pancreatic cancer phenotype in vitro, providing innovative insights on 
pancreas carcinogenesis processes. Conclusive remarks regarding the experimental 
results are reported by following for each of the topical activities that have been 
addressed and implemented during the thesis work. 
5.1 Three-Dimensional Polyelectrolyte Complexes Hydrogels 
based on Chitosan and Poly(γ-Glutamic Acid): Preparation and 
Physical-Chemical Characterization 
During this experimental work, polyelectrolyte complexes (PECs) and microstructured 
polyelectrolyte complexes (mPECs) hydrogels were prepared by mean of freeze-drying 
and computer-controlled wet-spinning technique, respectively. For the development of 
mPECs hydrogels, a design and optimization of the processing parameters was 
performed. The developed computer-controlled wet-spinning protocol allowed for the 
production of three-dimensional (3D) structures with controlled and reproducible 
internal microarchitecture and external shape by collecting with a predefined pattern a 
solidifying filament of chitosan (CS) and CS/poly(γ-glutamic acid) (γ-PGA) solution into 
a coagulation bath. All the hydrogels were characterized from a physical-chemical and 
morphological point of view. In this respect, scanning electron microscopy (SEM) 
analysis showed an interconnected porous structure for both kinds of hydrogels. The 
swelling behavior results showed that all the samples swelled rapidly, reaching 
equilibrium within 1 h. Moreover all the hydrogels preserved their physical integrity 
upon incubation in phosphate buffered saline 1X (PBS1X) and in Dulbecco's Modified 
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Eagle Medium (DMEM) up to 20 days, indicating that PECs and mPECs could be used 
for long-term cell culture applications. The formation of ionic complex interactions 
between chitosan and γ-PGA was confirmed through Fourier transform infrared (FT-IR)	  
spectroscopy analysis. The ordered microstructured and the addition of γ-PGA 
influenced mechanical properties of the produced mPECs hydrogels by enhancing their 
rigidity. Thermal analysis revealed good thermal stability of mPECs hydrogels and good 
miscibility of the two components in both kinds of hydrogels. Taken together, these 
results suggest the suitability of the prepared hydrogels as 3D reproducible scaffolds for 
in vitro cancer cell studies. 
5.2 Biocompatibility Assessment of Polyelectrolyte Complexes 
Hydrogels 
One of the essential requirements for promoting three-dimensional (3D) growth of cells 
in vitro is to design a suitable polymeric scaffold that provides a structural template for 
cell adhesion and growth. In this respect, it is necessary to submit the developed 
constructs to preliminary biological evaluations for the assessment of their 
biocompatibility. Hence, during this research activity, preliminary biological 
investigations of polyelectrolyte complexes (PECs) and microstructured polyelectrolyte 
complexes (mPECs) hydrogels were carried out. Biocompatibility studies revealed that 
mPECs hydrogels were non-toxic and suited for the adhesion and proliferation of both 
fibroblasts Balb/3T3 clone A31 and human pancreatic cancer BxPC-3 cell lines. In 
particular, BxPC-3 cells seeded onto mPECs expressed cell viability values compared 
with cells grown onto two-dimensional (2D) monolayer up to 28 days. Moreover in vitro 
biological evaluations of cell morphology of mPECs hydrogels showed encouraging 
results in terms of cells adhesion and spreading. In fact, BxPC-3 cells grown onto 
mPECs hydrogels showed a complete multicellular coverage of the fibers. By comparing 
mPECs to the analogues PECs hydrogels prepared by freeze-drying, it emerged how the 
manufacturing process and the final structure can greatly influence pancreatic cancer 
cells adhesion and proliferation, thus mPECs hydrogels were selected as a potential 
candidate for further biological investigations. 
5.3 Modeling of Pancreatic Ductal Adenocarcinoma in vitro with 
Three-Dimensional Microstructured Polyelectrolyte Complexes 
Hydrogels 
At present, data on three-dimensional (3D) tissue culture models of pancreatic cancer are 
very limited. Hence, the growth of pancreatic cancer cells in a 3D hydrogel substrate, 
able to overcome the drawbacks related to the traditional pancreatic cancer cells cultured 
in vitro could provide insights on pancreas carcinogenesis and on new therapeutic target 
for inhibition of tumor progression. In this respect, a great part of this PhD research 
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activity was dedicated to a comprehensive biological investigation of microstructured 
polyelectrolyte complexes (mPECs) hydrogels using human pancreatic cancer cells 
BxPC-3 in order to evaluate the ability of the hydrogels to support and maintain 
pancreatic cancer phenotype. The biological results obtained from confocal laser 
scanning microscopy (CLSM) analysis displayed that BxPC-3 cells cultured in 3D 
maintained the cancer features typical of the cell line, such as loss of cell polarity and 
duct-like structures differentiation. Moreover, BxPC-3 cells grown onto mPECs 
hydrogels formed multicellular spheroids that were not observed in two-dimensional 
(2D) monolayer culture. Furthermore, it is well known that tumor cells transformation is 
associated with protein overexpression. In this respect, fascin protein was selected as 
marker of tumor invasiveness, and its overexpression was investigated by CLSM and 
fluorescent western blotting. CLSM displayed that fascin protein was highly present in 
pancreatic cancer cells grown in 3D differentiating them from 2D monolayer cultures. 
Fluorescent western blotting (which was performed for the first time to detect fascin 
protein expression) confirmed the results obtained from CLSM. Several studies have 
shown the involvement of inflammatory or proinflammatory cytokines in pancreatic 
cancer development and aggressiveness, hence the expression of several cytokines 
associated with pancreatic cancer invasiveness was investigated by luminex technology 
and the results revealed that BxPC-3 cells cultured on mPECs hydrogels expressed high 
levels of cytokines involved in tumor aggressiveness. BxPC-3 cells grown onto mPECs 
hydrogels demonstrated to be able to maintain pancreatic cancer phenotype up to 40 days 
of culture and to organize into spheroids, thus suggesting that the developed mPECs 
hydrogels could represent a promising model for the maintenance of pancreatic cancer 
phenotype in vitro, providing innovative insights on pancreas carcinogenesis processes. 
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